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Clinical sample preparation is an essential process in modern diagnostics for 
maximizing sensitivity and specificity of detection and for ensuring reliability of assay 
readout. In general, sample preparation typically involves isolating and concentrating 
a population of target molecules, cells, or particles together with the removal of 
undesired components from specimen that could otherwise interfere with target 
detection. The identification of bacteria from complex clinical matrices such as blood 
presents a particular sample preparation challenge. Conventional culture-based 
methods typically require at least 24 h of incubation time, making this approach 
unsuitable for use in rapid diagnostics. Therefore, the development of sample 
preparation methods for bacteria with rapid processing time, high purification 
efficiency, and large volumetric throughput to enable analysis of low bacteria 
concentrations in blood remains a key challenge. 
  
This dissertation is focused on realizing a universal platform for preparing microbial 
sample from blood that is free lysis buffer, electric field, or affinity-based capture 
methods. First, we developed the porous silica monolith elements integrated into 
thermoplastic devices for isolation of intact bacteria from blood, enabling the 
application of emerging detection methods that supports bacterial identification from 
purified cell populations. Second, to support high throughput analysis of blood samples 
procured in resource-limited environments, microfluidics elements integrated directly 
into a syringe are demonstrated by utilizing the deterministic lateral displacement 
technique and the Dean flow focusing methods. Through these approaches blood cell 
reduction prior to bacteria isolation can be achieved, thereby increasing the overall 
sample volume that may be processed by the system. Additionally, a miniaturized 
hydrocylone capable of operating at tens of milliliters per minute feed rate is presented. 
Complex microstructures successfully realized at a hundred-micron scale by 3D 
printing technique presented a promising route to the unconventional microfluidic 
systems. Lastly, we demonstrated ancillary microfluidic components required to enable 
full operation of the system in a low-cost lab-on-a-chip format suitable for 
implementation in resource-limited environments and optimize overall operation of the 
platform to achieve throughput, sensitivity, and selectivity suitable for clinical 
application when coupling the platform with downstream detection methods designed 
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Chapter 1: Introduction 
 
1.1. Lab-on-a-Chip Technology for Point-of-Care Diagnostics  
Point-of-care (POC) medical diagnostics offer enormous potential for enabling 
more rapid, effective, and personalized disease monitoring and treatment.1–6 
Distinguished from the traditional healthcare settings, in which diagnostic testing is 
performed over large numbers of patient samples using high throughput equipment 
located in a centralized clinical laboratory, the future of healthcare technology is 
advancing toward a model where a wide range of diagnostic tests can be performed in 
near-patient settings, ranging from small clinics to the patient’s bedside, to acquire 
individualized assay results with minimum delay, benefitting the clinical decision-
making process and patient outcomes. The application of POC testing has already been 
successfully commercialized in recent decades, with widely available POC assays 
including glucose monitoring,7–10 pregnancy test,11,12,13 blood coagulation test,14 and 
troponin monitoring for acute myocardial infarction (AMI).15,16 With recent 
technological advances, POC testing has been further adapted to various genetic 
diagnostics, enabling early-stage disease detection by analyzing genetic clues in the 
blood. For example, advanced detection techniques such as electrophoresis,17 
impedimetric sensing,18–20 colorimetric assays,21–23 nucleic acid amplification 
techniques such as polymerase chain reaction (PCR), and advanced optical techniques 





demonstrated for detection of infectious diseases, inflammatory response, and 
cancers.2,24,25  
In 1980s, a new concept called “lab-on-a-chip (LOC)” system was envisioned 
as a new solution for the development of highly integrated POC diagnostics, and many 
of the advantages of this approach were outlined in a seminal paper by Andreas Manz 
in 1989 which introduced the idea of a “micro total analysis system”26,27 The idea of 
combining microelectromechanical systems (MEMS) and microfluidic technologies 
enables miniaturization of conventional clinical lab tests and integration of multiple 
benchtop techniques into a small device, offering great advantages including short 
turnaround time, minimal reagent usage, portability, low cost, low energy 
consumption, and facile mass transport and measurements.28–30 While numerous 
studies have advanced the development of new detection techniques capable of 
enhancing sensitivity and detection limits of diagnostic sensor based on microfluidic 
technology, other essential components of POC diagnostics such as sample preparation, 
reagent storage, and fluidic control have received less attention by the research 
community. The work in this dissertation seeks to address these tasks as essential 
challenges to realize true POC diagnostics, with a particular focus on improving key 
aspects of sample preparation, and ease-of-operation for microfluidic POC diagnostics 
suitable for use in near-patient environments.       
1.2. Lab-on-a-Chip Techniques for Clinical Sample Preparation 
Molecular targets suitable for POC diagnostics must be analyzed from patient 





confounding components including intact cells, proteins, lipids, small molecules, and 
ionic species that can interfere with effective target identification and qualification. As 
a result, sample preparation is typically required to isolate and purifying target 
components from complex biological samples collected from a patient. 
Conventionally, the quality of sample preparation can be described by the purity of a 
target component within a processed sample. Insufficient isolation or concentration of 
the desired target can lead to poor sensitivity or inaccurate results due to the 
interference caused by other constituents present in the sample. Also, because of the 
sensitive nature of many biological substances to ambient environmental conditions, 
maintaining specimen integrity throughout the sampling, storage, and preparation 
process is a critical concern. Therefore, even in modern healthcare services, 
conventional sample preparation has been heavily centralized in clinical laboratories 
where special equipment, reliable sample storage, and highly-trained personnel are 
available.  
A significant advantage of LOC platforms is the potential for sample 
preparation to be integrated directly into the same microfluidic system used for the 
assay itself. In established LOC platforms, sample preparation typically demonstrated 
by isolating target object via microfluidic-based separation techniques by utilizing 
size,31–33 binding affinity,34,35 electrokinetic properties.36–38 Microfluidic separation can 
be broadly classified as active and passive techniques by the necessity of external force 
field to induce the migration of the target. For example, active separation techniques 
like dielectrophoresis (DEP) and electrophoresis (EP) require electric field, and 





acoustic waves, and magnetophoresis (MP) needs magnetic bead labeling and 
electromagnets around microchannel. A strong advantage of active separation is that it 
can achieve cell separation without pressure-driven fluid flow, eliminating the needs of 
bulky fluid control accessory such as syringe pump. However, its operation is still 
limited outside of the clinical facility, because controlling external fields becomes 
extremely difficult without off-chip controller and the precision of force control also 
dominantly rely on this equipment.  
Passive separation technique only relies on geometry of microchannel and 
intrinsic hydrodynamic forces.39,40 A fluid flows within a microchannel generally 
exhibits the flow profile of laminar flow, which can be characterized by low Reynolds 
number (Re). At very low Reynolds number, fluid inertia becomes negligible compared 
with viscous forces and flow behavior can be approximated to the case of Stokes flow. 
There are many passive separation techniques that take advantage of well-defined 
streamlines in both low and intermediate Re flow regimes.38,41–43 For example, 
deterministic lateral displacement (DLD) is a passive size-based separation technique 
well suited for effective size-based particle separation during Stokes flow.44–46 The 
mechanism of DLD separation is based on the interaction of a particle within the Stokes 
flow and an ordered array of micrometer-sized posts. Two different particle migration 
modes can occur within a DLD device; a particle smaller than a critical size flows along 
the direction of bulk flow, whereas a particle larger than a critical size is forced to 
migrate into neighboring stream at a gap between microposts, forming isolated streams 
of particle at different lateral positions. A flow within the intermediate range of 





various fascinating phenomena, such as inertial focusing, pinched flow fractionation, 
and Dean flow focusing. Inertial focusing is a phenomenon that particles migrate to 
equilibrium positions on the cross section of the channel based on the characteristics of 
particles. This phenomenon is based on the force balance between two inertial forces, 
the shear-induced lifting force generated by fluid velocity gradient from the center of 
channel to the channel wall and the wall-induced lifting force caused by the interaction 
of a particle and the wall.40,47–49,41,42,50 As mentioned earlier, channel geometry is 
another essential factor in passive separation techniques. Various studies has revealed 
that the curved microchannel structure can induce secondary flow that can trigger 
unique particle movement. A microchannel that has a pinched section shows a unique 
phenomenon called the pinched flow fractionation. Particles enter into the pinched 
microchannel forced to align at the same position regardless of the size. When flow 
meets the broadened microchannel segment, larger particles experience a force toward 
center of the stream whereas smaller particles experience a force toward the wall 
yielding separate focused streams of particle by size.51–53 A related approach employs 
curved microchannel such as a spiral geometry38,42 or asymmetric wave shape,39,50 to 
separate particles within size-dependent streamlines based on another phenomenon 
called Dean flow focusing. In a curved microchannel, a secondary flow appears within 
the channel cross section due to centrifugal forces. This results in two counter-rotating 
vortices perpendicular to the main flow direction, called Dean vortices. Drag force 
caused by Dean vortices competes with lift forces between the particles and 
microchannel walls, enabling particle focusing by size at significantly higher Reynolds 





Despite the advancement of microfluidic technologies over the past several 
decades, realization of LOC separations for effective sample preparation from 
clinically-important matrices such as blood still poses several challenges, including the 
need for robust and high-throughput separation, wide range of separability, and simple 
and easy operation without the need for significant instrumentation or infrastructure. 
While passive separation techniques such as those described above have partially 
fulfilled these challenges, typical implementation still requires multiple pumps to 
manipulate flows precisely, and the techniques are only applicable when the target size 
is significantly different from other particles in the sample. Thus, developing a new 
versatile system for clinical sample separation would catalyze the realization of a new 
generation of LOC platforms for near-patient diagnostics.  
1.3. Thermoplastics as Material for Lab-on-a-Chip 
Cost is another significant constraint that limits the potential of many existing 
microfluidic technologies. To become a practical technology, inexpensive and scalable 
manufacturing is a key challenge for LOC devices. Because LOC technology was 
originally derived from MEMS fabrication, traditional LOC devices were mostly 
fabricated in glass or silicon wafers that are high-cost, fragile material for POC 
testing.54,55 In addition, bonding of glass or silicon requires high temperature or high 
voltage process and devices need to be prepared in a cleanroom environment. Soft 
lithography of silicone elastomers such as poly(dimethylsiloxane) (PDMS) has gained 
enormous attention from many researchers because of its simple cast-and-cure 
fabrication, enabling rapid prototyping from a mold prepared via traditional MEMS 





and the material is not ideal for many POC diagnostic applications due to issues 
including high water absorption, high gas permeability, and poor solvent resistance. 
Thus PDMS is unsuitable for practical clinical applications requiring the mass 
production of low cost POC diagnostics.55–57 Thermoplastic materials including 
polycarbonate (PC), polymethylmethacrylate (PMMA), and cyclic olefin polymer 
(COP) are another common class of materials used for the fabrication of LOC devices. 
Unlike PDMS, thermoplastics generally exhibits attractive intrinsic properties for LOC 
application such as inexpensive cost, high optical clarity and low auto-fluorescence 
over wide range of wavelengths, low water absorption, excellent acid/base resistance, 
and high bond strength.58 Among the general class of thermoplastics, COP has been 
envisioned as a promising material based on excellent UV transparency, extremely low 
water absorption, and superb solvent resistance.55,59 In addition, thermoplastic-based 
LOC devices take advantage of traditional replication-based thermoplastic fabrication 
methods including hot embossing, injection molding, roll-to-roll printing, micro 
milling as well as bonding techniques such as thermal fusion bonding, solvent-assisted 
bonding, and surface modification-aided bonding. Benefitting from these advantages, 
COP has already begun to be commercialized in various medical products such as pre-
fillable syringe, clinical vials, and medicine packaging, making COP a promising 
material for high performance and low cost LOC devices.            
1.4. Dissertation Approach and Organization  
This dissertation describes the development of a suite of technologies 
supporting critical aspects of LOC sample preparation and system automation for POC 





challenges for both sample preparation and automation, this work is primarily focused 
on the case of diagnostics for the analysis of microbial targets from blood. The aim is 
to develop novel microfluidic separation systems that are inexpensive, disposable, 
portable, easily operable with minimal off-chip equipment (e.g. no external electric 
fields or precision syringe pump), and free of the need for external reagents such as 
lysis buffer, or affinity-based capture probes. 
The dissertation is organized into six chapters. In the following chapter 
(Chapter 2) an intact separation of bacteria and selective lysis of blood cell from whole 
blood is demonstrated using a porous silica monolith element integrated into a 
thermoplastic microfluidic device. Unlike conventional microfluidic size-based 
separation methods, this study employs a silica monolith with micron-scale pore 
diameter to induce mechanical lysis of blood cells while allowing intact passage of 
bacteria with a simple flow-through operation. In addition, selective lysis of blood cells 
in the device results in smaller cell lysates than chemical buffer-induced lysis, allowing 
for effective size-based downstream separation by taking advantage of the significant 
size difference between intact bacteria and other constituents present in the post-
monolith flow. The porous silica monolith for whole blood operation is synthesized in 
a brick format and highly scalable, making large quantity fabrication of the device 
feasible. Chapter 3 presents a syringe-based microfluidic system capable of reducing 
the initial blood cell population while also collecting the initial blood specimen from 
patient. This study employs a novel thermoplastic soft lithography technique to pattern 
microfluidic features on a thin film that later seamlessly integrated onto a cylindrical 





deterministic lateral displacement and Dean flow focusing. The resulting “smart 
syringe” integrates a microfluidic separator into a conventional clinical tool, which will 
aid sample preparation steps without the need for complex instrumentation. In chapter 
4, high throughput particle separation is demonstrated using a millimeter scale micro 
hydrocyclone fabricated via 3D printing. SLA-DLP additive manufacturing was 
employed to realize a complex internal 3D structure of the micro hydrocyclone (µHC) 
at the scale of ~100 µm, enabling the realization of microfluidic geometries that are 
extremely difficult or impossible to achieve using conventional silicon or polymer 
microfabrication techniques. Together with computer-aided design, an interfacing port 
that is compatible with conventional tools is readily integrated onto the device, 
allowing a simple fluidic interfacing. The resulting µHC is capable of separating sub-
micrometer particles from milliliters of suspension within a few seconds. This 
demonstration reveals the promising of high resolution 3D printing for the realization 
of unconventional microfluidic designs as well as a potential of miniaturized 
hydrocyclone for clinically-relevant cell separation. In chapter 5, a low-cost, portable, 
programmable micropump is developed to aid the operation of LOC diagnostics with 
precise fluid actuation without the need for expensive and bulky precision syringe 
pumps, making the system well suited for diagnostic applications in resource-poor 
environments. This technology employs disposable thermoplastic devices integrated 
with stainless steel screws, and an elastomer ball to not only support integrated 
pumping but also seal fluids within the device for on-chip reagent storage. Utilizing an 
Arduino-based microcontroller, precise flow control is demonstrated over a dynamic 





minute. The resulting micropump operates on a battery pack, and software-defined flow 
manipulation enables complex fluidic operation such as droplet generation with 
precision in a completely remote setting. This chapter is adapted from Han et al.60 
Finally, chapter 6 present a summary of the work and primary contributions, and 
outlines potential future directions for advancing the individual microfluidic 





Chapter 2: Isolation of Intact Bacteria from Blood by Selective 
Cell Lysis in a Microfluidic Porous Silica Monolith 
 
2.1. Summary 
In this chapter, the isolation of intact bacteria from whole blood is demonstrated 
through the use of selective lysis of blood cells during flow through an on-chip porous 
silica monolith. Efficient mechanical hemolysis of blood cells is achieved while 
providing intact passage of bacteria through the monolith, allowing size-based isolation 
of bacteria following selective lysis. A process for synthesizing large quantities of both 
discrete capillary-bound monolith elements and millimeter-scale monolith bricks 
together with the seamless integration of individual monoliths into thermoplastic 
microchannels is described. Using this fabrication approach, the impact of monolith 
morphology, geometry, and flow conditions on cell lysis is explored, and flow regimes 
are identified wherein robust selective blood cell lysis and intact bacteria passage may 
be achieved for a variety of both gram-negative and gram-positive bacteria.  
2.2 Introduction 
The presence of bacteria in the blood stream can lead to serious conditions 
including sepsis and bacterial infection of other tissues, and rapid identification of 
blood-borne bacteria is necessary to identify optimal treatment strategies and 
maximizing the survival rate of patients. The ability to rapidly identify bacteria at or 
near the point of care would greatly enhance the ability of clinicians to initiate optimal 





The current gold standard assay for bacterial characterization is based on phenotypic 
analysis in cell culture, requiring at least 24 h to several days between sample 
collections, analysis in a clinical microbiology laboratory, and diagnostic answer.61–63 
While phenotypic analysis is relatively inexpensive, this method cannot generate 
timely results and thus cannot be used to guide the initial stages of treatment.64 
While analytical methods enabling culture-free detection and identification of 
bacteria from clinical blood samples are emerging, such as real-time polymerase chain 
reaction (qPCR),24 Raman spectroscopy,25 mass spectroscopy,65 and infrared 
spectroscopy,66–68 these techniques commonly require the isolation and purification of 
bacteria from blood. The use of affinity capture to immobilize bacteria on magnetic 
beads for subsequent removal from the initial blood sample has been widely 
explored.34,35,69 Magnetic pull-down of bacteria can be highly efficient, but requires the 
introduction of reagents and instrumentation that complicate assay operation. As an 
alternative to affinity-based separation, the use of size-based separation of bacteria 
from other blood components has been demonstrated using various microfluidic 
platforms employing inertial deflection,32 inertial lift,31 or Dean flow fractionation.33 A 
central advantage associated with inertial microfluidics for bacteria isolation is that 
separation may be performed in a continuous flow process without the need for 
additional reagents or equipment other than a pump to control sample flow in the 
system. However, inertial separations generally require precise control over flow rates 
to ensure accurate fractionation and can only be applied to smaller bacteria with 





various strains of Escherichia coli and Bacillus subtilis have major axis lengths on the 
order of 6-8 µm,70 similar to the diameter of human red blood cells. 
To overcome the constraints associated with these active separation methods, 
an alternate strategy involves the selective lysis of blood cells under conditions that do 
not disrupt target bacteria. In this way a secondary size-based separation may be 
performed to remove small cell lysate particles, resulting in isolated and purified 
bacteria for downstream analysis. This approach was recently explored in a 
microfluidic platform designed for selective chemical lysis a combination of detergent 
and osmotic shock,71 enabling highly efficient selective passage of intact and viable 
bacteria. However, on-chip chemical lysis requires control over multiple solution 
flows, and the use of detergents or chaotropic agents to permeabilize cell membranes 
can potentially impact the performance of downstream assays. Additionally, dilution 
of the lysate is required to prevent damage to target pathogens by ongoing osmotic 
shock, resulting in low final bacteria concentration using this approach. 
In the present work, we explore the use of microfluidic-integrated porous silica 
monoliths as a simple flow-through method for selective blood cell lysis and intact 
bacteria isolation. Monoliths are highly porous materials with an open cell morphology 
that presents tortuous flow paths for fluids forced through the structures.72 With 
appropriate control over pore dimensions, the porous morphology serves to induce high 
mechanical surface stress during cell perfusion through the porous network, enabling 
mechanical hemolysis of blood cells while maintaining the integrity of bacteria 





may be achieved for bacteria spiked in human whole blood under flow conditions that 
yield highly efficient blood cell lysis. The technique is also shown to result in smaller 
blood cells fragments than chemical lysis, thereby conferring a greater size difference 
between bacteria and lysate particles for improved downstream separation. Selective 
passage of intact and viable bacteria was achieved for gram positive as well as gram 
negative species, in spite of the thinner peptidoglycan layer associated with gram 
negative bacteria that reduces mechanical robustness of the cell wall.73,74 The technique 
is first investigated using small cylindrical monoliths segments synthesized within 
silica capillaries, and expanded to a higher throughput format using large silica 
monolith bricks seamlessly integrated into thermoplastic microfluidic chips. 
2.3. Materials and Methods 
2.3.1. Materials 
Tetramethyl orthosilicate (TMOS, ≥99%), ethanol (≥99.5%), methanol 
(≥99.8%), isopropanol (≥98%), acetic acid (ACS reagent, ≥99.7%), polyethylene 
glycol (PEG, 10k mw), urea, Tris(hydroxymethyl)aminomethane (TRIS), phosphate 
buffered saline (PBS, tablet), bovine serum albumin (BSA, powder), and Tween 20 
were purchased from Sigma-Aldrich (St. Louis, MO). Methyltrimethoxysilane 
(MTMS, 97%), sodium hydroxide (10 N, aqueous), and decalin (cis + trans, 98%) were 
obtained from Alfa Aesar (Haverhill, MA). Enterobacter cloacae, Micrococcus luteus, 
Bacillus subtilis, and Lactococcus lactis were obtained from the United States 
Department of Agriculture Agricultural Research Service (USDA ARS). Tryptic soy 





purchased from Carolina Biological (Burlington, NC). Fused silica capillary tubing of 
100 μm ID and 360 μm OD was purchased from Molex Connector (Lisle, IL) Upchurch 
fittings were purchased from IDEX Health & Science LLC. (Oak Harbor, WA). Iridium 
heat shrink tubing (500 μm initial ID, 250 μm final ID) was obtained from Cobalt 
Polymers (Cloverdale, CA). Thermoplastic 1020R cyclic olefin polymer (COP) pellets 
were purchased from Zeon Chemicals (Louisville, KY). 
2.3.2. Preparation of Capillary and PMMA Mold 
Fused silica capillary was cut into 1 m long segment, then infused with 1 M 
sodium hydroxide solution. A capillary segment was sealed with the upchurch fittings, 
then incubated for 3 h in 40 ˚C oven. After incubation, a segment is thoroughly rinsed 
with deionized water and methanol, and dried in vacuum oven for 6 h at 50 ˚C. A mold 
for large silica monolith synthesis was prepared by micromachining poly(methyl 
methacrylate) (PMMA) plates using a computer numerical control (CNC) milling 
machine (MDX-650A; Roland, Lake Forest, CA). 380 μm and 4 mm diameter endmills 
were used to make 7 cm long straight channels with 4 mm x 4 mm cross sectional area. 
PMMA substrates were cleaned by sonication in deionized water and dried completely 
in vacuum oven. Metastable thermal bonding was achieved by exposing both PMMA 
substrates under UV/ozone cleaner for 1.5 min and pressed together at 400 psi, 75 ˚C 





2.3.3. Silica Monolith Preparation 
The silica monolith synthesis process, summarized in Figure 2.1, was modified 
from reported studies.75–79 The precursor mixture was prepared by adding 0.5 g of PEG 
and 1.015 g of urea into 10 mL 0.01 M acetic acid solution, and stirred vigorously in 
an ice bath. Once the components were fully dissolved, TMOS and MTMS 85:15 v/v 
were mixed and added to the acetic acid solution and stirred for 40 min in an ice bath. 
The mixed solution was then infused through a 0.22 μm PVDF syringe filter (Millipore, 
Billerica, MA) into either a silica capillary segment or into a PMMA mold through the 
same syringe filter. The infused capillary and mold were tightly sealed with upchurch 
fittings to prevent solvent evaporation, and thermally treated at 40˚C for 12 h, then 
Figure 2.1. (a) Synthesis of porous silica monolith in fused silica capillary and 
thermoplastic mold via sol-gel chemistry. (b) Competitive reactions during the 
synthesis of monolith. Silanol groups present on glass capillary form covalent 





gradually heated to 80 °C over a 6 h period, followed by 15 h incubation at 80 °C to 
trigger urea decomposition. After thermal treatment, the silica capillary or PMMA 
mold was allowed to slowly cool to room temperature by natural convection.  
To complete the preparation of the capillary monoliths, the capillary mold was 
cut into approximately 12 cm long segments after discarding about 10 cm from each 
end and submerged into a large methanol bath for 3 days, followed by submersion in a 
deionized water bath for 1 day while replacing each solvent every 6 h to remove 
unreacted reagents. For monoliths synthesized in a PMMA mold, the mold was opened 
by gently pushing a razor blade into bonding interface, the silica gel rods were collected 
and rinsed by submersion into a methanol bath for 1 day and deionized water bath for 
1 day, with fresh solvents replaced every 6 h. Rinsed capillaries and silica gel rods were 
dried at 60 °C in an oven for 12 h under atmospheric pressure, then moved into a high 
Figure 2.2. Fabrication process for a capillary-integrated monolith chip for 
selective lysis. Following monolith synthesis and capillary dicing to form short 
monolith elements, the capillary segments are inserted into a thermoplastic COP 
chip containing a capillary clamp zone that reflows during solvent bonding to 





temperature furnace. Calcination was completed by heating at 330 °C for 25 h, 
removing organic components and leaving porous silica structures. For the capillary 
segments, an additional 2 cm length from each end was discarded. The remaining 
middle portion was the cut to desired lengths ranging from 500 μm to 1500 μm using a 
wafer dicing saw (1006A; Micro Automation) equipped with a diamond blade. Porous 
silica rods were similarly cut into 2 mm long bricks using the dicing saw.  
2.3.4. Microfluidic Device Fabrication and Monolith Integration 
Porous silica monolith capillary segments were integrated into COP 
thermoplastic chips using the process described in Figure 2.2. Upper and lower COP 
substrates were patterned with a CNC milling machine, using 150 μm and 380 μm 
diameter end mills to form a short region in the middle and large mating channel 
features on both substrates, respectively. The channels in each substrate were machined 
to a depth of 250 μm, except for short regions with a depth of only 75 μm. This shallow 
region serves as a capillary clamp designed to deform during chip bonding, such that 
Figure 2.3. Image of a 3 mm long capillary segment integrated within a 
thermoplastic chip, with reflow of the capillary clamp structures during bonding 
resulting in complete sealing around the periphery of the capillary. Scale bar is 500 





reflow of polymer in the clamp region fully seals the flow path around a capillary 
placed in the channel. After machining the chip substrates, each layer was cleaned by 
sonication in methanol, acetone, and deionized water, then dried overnight in a vacuum 
oven. Both substrates were next exposed for 1.5 min to a decalin/ethanol (33/67 vol%) 
solution, which serves to enable solvent bonding of the COP layers as described 
previously80,81 and to soften the capillary clamp structures to support polymer reflow 
during the bonding process (Figure 2.3). After solvent exposure, a capillary segment 
was manually inserted into the lower substrate channel with the center of the capillary 
approximately aligned to the capillary clamp structure. The upper substrate was finally 
placed onto the lower substrate, with the capillary serving to self-align both layers, and 
the assembly was placed in a hot press to apply a pressure of 500 psi for 5 min at 35 
°C.  
Figure 2.4. Assembly of a capillary monolith device using heat shrink tubing. (a) 
Porous silica monolith capillary element was placed into a heat shrink tubing 
segment, with a long inlet capillary abutting the monolith element on end and a 
short outlet capillary on the other end. (b) Magnified view of the monolith element 
and inlet/outlet capillaries in the heat shrink tubing before heat activation. (c) The 






For selected experiments, capillary segments were also assembled with empty 
capillaries using heat shrink tubing, enabling simpler fluidic interfacing and quicker 
device fabrication. A porous silica monolith capillary element was placed into a heat 
shrink tubing segment, with a long inlet capillary abutting the monolith element on end 
and a short outlet capillary on the other end. The assembly was then placed in an oven 
at 120 °C for 5 min to activate the heat shrink tubing and permanently seal the flow 
path (Figure 2.4).  
For high throughput device fabrication, porous silica monolith bricks were 
integrated into COP thermoplastic chips by the process shown in Figure 2.5. Prior to 
milling, COP pellets were formed into 4 mm and 2 mm thick plaques using a hot press. 
Using a CNC milling machine, a 2 mm diameter and 3 mm deep hole was first formed 
Figure 2.6. (a) Integration process of a large silica monolith brick into a 
thermoplastic chip. A circular tape is attached to protect fluidic path of monolith 
brick, and solvated COP is applied via doctor blade. Once it solidifies, protection 
tape is removed, and device is enclosed with another COP substrate. (b) SEM image 
of monolith brick cut by wafer dicing saw. (c) A device in operation using whole 
blood. A red mark appears at the central area of a monolith during whole blood test 









in a 4 mm thick lower substrate, together with a 3 mm square and 2 mm deep socket 
for the monolith brick, resulting in a square socket for monolith insertion and a 1 mm 
deep, 2 mm diameter indentation at the bottom of the socket. An additional 3.2 mm 
wide and 100 μm deep slot was milled around the perimeter of the socket. This slot 
served as a receptacle for solvated COP to improve sealing of monolith during the final 
bonding step. Next, a 2 mm diameter and 1 mm deep hole was milled in a 2 mm thick 
upper COP substrate, and needle ports for external fluidic interfacing were formed on 
both substrates using a 650 μm drill bit to connect the inlet and outlet needles to the 
device. Each COP substrate was sonicated in methanol, acetone, and deionized water, 
and dried overnight in a vacuum oven. A 2 mm diameter circular section of pressure-
sensitive wafer dicing tape (blue tape) was patterned using a 2 mm diameter PDMS 
punch and adhered to the center of a porous silica brick to protect the fluidic path during 
monolith integration. In this process, the lower COP substrate was exposed to a 
decalin/ethanol (33/67 vol%) solution for 2 min, and the silica monolith brick was 
manually inserted into the monolith socket. After insertion, a solvated COP solution, 
prepared by slowly dissolving COP pellets in decalin to a concentration of 30 wt%, was 
applied to the lower substrate with inserted silica brick using a doctor blade. The lower 
substrate was dried for 2 h at room temperature to evaporate decalin and to solidify the 
solvated COP, after which the protection tape was carefully removed from the 
monolith. Next, the lower and upper substrates were exposed to the same 
decalin/ethanol solution for 45 s and 2 min, respectively, and bonded together in a hot 
press at 300 psi for 5 min at 35 °C. Bonded devices were dried overnight in a 60 °C 





2.3.5. Selective Blood Cell Lysis and Bacteria Passage 
Four bacteria were selected to investigate selective passage through the silica 
monoliths, namely E. cloacae (gram negative, 0.3-0.6 μm diameter and 1-2 μm length), 
B. subtilis (gram positive, 0.25-1.0 μm diameter and 4-10 μm length), L. lactis (gram 
positive, 0.5-1.5 μm diameter coccus or ovoid), and M. luteus (gram positive, 0.5-3.5 
μm diameter coccus). Each bacteria was obtained as lyophilized powder, and grown in 
TSB, LB, NB media for 24 h at 25-30 °C with gentle agitation. Resulting bacteria 
suspensions were pelletized by centrifugation, and re-suspended with autoclaved 1x 
PBS solution after discarding supernatant. Final bacterial concentration was adjusted 
to give 30-300 CFU per cultivation plate, enabling accurate quantification of viable 
bacteria passed through the silica monoliths. For blood lysis tests, whole blood was 
collected in a 6 mL vacuum container with K2 EDTA sprayed on the interior, and 
diluted with 1x PBS solution to specified levels prior to use. 
2.4. Results and Discussion 
2.4.1. Porous Silica Monolith Synthesis 
Porous silica synthesis involves a competitive process of sol-gel transition and 
separation into a co-continuous binary phase via spinodal decomposition of a liquid 
mixture of alkyl silicates and porogen in acidic solution.72,79,82 Hydrolysis and 
condensation of silica are the major reactions which enable the formation of silica glass 
from liquid alkyl silicate at relatively low temperature.83 As the chemical reactions 
progress, entropic loss from the condensation of two silanol groups increases the Gibbs 





hydrolysis under acidic conditions is required to uniformly hydrolyze most of alkyl 
silicates, followed by a gradual increase in pH to suppress the hydrolysis and to boost 
the condensation reaction, which allows homogeneous phase separation in the mixture 
without macro-phase separation.72,83,84 As described in Figure 2.1, our silica monolith 
was prepared from a precursor solution composed of alkyl silicates, PEG as a porogen, 
urea as a source of hydroxyl ions, and acetic acid as a solvent. The addition of urea in 
the starting mixture was found to be important for minimizing heterogeneity of porous 
morphology. Unlike conventional methods for making porous silica, urea can be 
thermally decomposed at temperatures above 80 °C in the presence of water leaving 
ammonia and carbon dioxide as products. This allows the hydrolysis and condensation 
reactions to be separated by increasing the pH of solution during reaction, thereby 
obviating the need for physical infusion of basic solution which can disrupt the soft gel 
phase, while enabling a more uniform pH increase throughout the entire gel. A mixture 
of TMOS and MTMS were chosen as sources of silica to overcome the intrinsic volume 
contraction associated with a pure TMOS recipe, in which four methoxy groups serve 
as crosslinking points during the condensation reaction. By using MTMS as an alkyl 
silicate with only three crosslinking points and one inert group, volume contraction was 






Optimization of this process resulted in monoliths that were homogeneous and 
well-anchored to the silica capillary walls (Figure 2.6). The excellent attachment of 
porous silica to the glass capillary is attributed to covalent bonding during condensation 
reaction between silanol groups on the capillary wall and the growing silica gel phase 
within the monolith. The thickness of the final skeletal monolith structure was 
measured as 2.0 ± 0.3 μm, with average through-pore dimensions of 2.4 ± 0.8 μm. 





Where μ is viscosity of a mobile phase, 𝑢𝑢𝐹𝐹 is superficial velocity, L is length of 
the silica monolith capillary, and ∆P is pressure drop across the capillary measured by 
high performance liquid chromatography (HPLC) pump. Permeability (𝐾𝐾𝐹𝐹) of porous 
silica monolith was 2.0 × 10-12 m2. To minimize the intrinsic variation in sizes caused 
by hydrothermal treatment and calcination, the resulting capillary was cut into 5 cm 
long segments and permeability was evaluated before use. 
Figure 2.7. SEM image of a silica monolith synthesized within a 100 µm ID fused 






2.4.2. Porous Silica Monolith Integration 
The integration of polymer monoliths into microfluidic systems by direct in situ 
photopolymerization of precursor solutions within on-chip microchannels has been 
widely demonstrated.75–77,80,86 To overcome issues of poor patterning resolution, 
incomplete sidewall anchoring, and large variations in pore size and monolith density 
associated with in situ polymerization,87 we previously developed a method for 
fabricating bare polymer monoliths off-chip, followed by integration of the discrete 
monolith elements into the final microfluidic system.88 This process can similarly be 
applied to silica monolith integration, allowing monolith insertion into chips 
manufactured from thermoplastics that are incompatible with the high processing 
temperatures required for in situ inorganic monolith synthesis. While effective, the 
reintegration process requires the use of trapezoidal channel cross sections and high 
pressure during bonding to ensure complete sealing of the bare monoliths, often 
resulting in fracture of the brittle silica structures. 
To avoid this complication, two fabrication methods for integrating silica 
monoliths into microfluidic systems were developed. In the first method, monolith-
containing capillary segments was used instead of bare monoliths, allowing the devices 
to take advantage of the rigid capillary wall which serves as a protective shell 
surrounding the monolith, allowing high pressures to be used during chip bonding 
without risk of monolith fracture. This approach eliminates the need for nonstandard 
channel geometry to ensure proper monolith sealing.88 A summary of the capillary 
device fabrication process is presented in Figures 2.2 and 2.3. While capillary clamps 





achieved by placing the deforming clamp structures in the upper layer alone, the bottom 
layer alone, or both layers together. 
While the integration of monolith-containing capillaries into microfluidic 
devices can take advantage of mechanical protection provided by the capillary itself to 
prevent damage to the monolith during the chip bonding process, the integration and 
sealing of bare silica monolith bricks presents a different challenge due to the brittle 
nature of the monolith material. Millimeter-sized monolith rods prepared in a PMMA 
mold were cut into 2 mm length by dicing saw, yielding small, crack-free monolith 
bricks (Figure 2.5(b)). To overcome poor sidewall sealing of monolith to COP 
thermoplastic chip, we utilized the viscous solution of COP dissolved in decalin, 
leveraging a technique previously reported by our group termed solvent casting,89 in 
which solvated COP can be applied to various non-flat surfaces and easily solidified 
by evaporating the solvent. When applied to a COP/monolith device, it can penetrate 
into the gap between the monolith and COP surface, forming an additional layer of 
COP surrounding the sides of a monolith. During solvent evaporation, the layer of 
solvated 
COP not only solidifies into a conformal COP film but also forms a permanent 
bond via solvent-mediated bonding. The application of solvent COP to the porous 
monolith also results in intrusion of liquid into the surface pores forming an intimate 
contact with the outer surface of the monolith, thus establishing highly stable sealing 
between the silica monolith and COP substrate. Unlike other techniques for the ex-situ 





contact between the monolith and substrate or the use of highly solvent-softened 
thermoplastic substrates, the present method was found to provide excellent reliability 
and leak-free operation even at high pressures required for whole blood perfusion 
through the devices. 
2.4.3. Bacterial Passage and Selective RBC Lysis in a Capillary Device 
To explore the efficiency of bacteria passage, we chose E. cloacae (gram 
negative, rod shaped), one of the common cause of hospital-acquired infection,90,91 and 
three gram positive bacteria with different shapes and sizes (L. lactis, M. luteus, B. 
subtilis). Each bacterium was perfused through a series of microfluidic monoliths with 
varying geometry and under varying flow conditions to evaluate the regimes under 
which the bacteria pass through the monolith without being lysed. 
First, samples of E. cloacae suspension and diluted blood were processed 
through 3 mm long monolith capillary-integrated devices and analyzed by dynamic 
light scattering (DLS). Despite the shape dependence in light scattering analysis, size 
difference between erythrocytes and E. cloacae were observed in two distinctive ranges 
for the unprocessed samples, with erythrocytes at 3-6 μm diameter (Figure 2.7(a)) and 
bacteria at around 0.8-2 μm diameter (Figure 2.7(b)). When analyzing 25× diluted 
blood, a strong peak at 3-4 μm is observed, reflecting the presence of intact RBCs in 
the sample. After processing through the monolith, this peak is nearly eliminated, with 
the primary components at the monolith outlet being particles below 1 μm. In contrast, 
perfusion of purified E. cloacae through the monolith yields no discernable change in 





lysis of erythrocytes also resulting in the appearance of smaller peaks, but with a wide 
distribution ranging from tens of nanometers to several micrometers (Figure 2.7(a)), 
presumably reflecting the presence of partially exploded cells, small fragments of cell 
membrane, and cytoplasm released by lysis. These results indicate that monolith 
passage results in more complete lysis of RBCs than chemical methods. 
Similar results were observed from tests using 100× diluted blood spiked with 
E. cloacae, as shown in Figure 2.8. Two significant peaks at around 100 nm and 1 μm 
match well with corresponding peaks from the diluted blood study (Figure 2.7(a)) and 
purified E. cloacae study (Figure 2.7(b)), respectively. Overall, these initial DLS 
results indicate that the porous silica monoliths can successfully pass intact bacterial 
cells while aggressively lysing red blood cells from a mixed clinical matrix.  
Figure 2.8. DLS measurement of (a) initial 25× diluted blood, chemically lysed 
blood, and blood lysed by perfusion through the monolith device, revealing a 
significant reduction in cell debris size for mechanical monolith lysis over chemical 
lysis. (b) DLS measurement of E. cloacae suspended in 1× PBS, and sample 





The RBS lysis efficiency was found to be strongly affected by the length of 
porous monolith (Figure 2.9). In particular, a wide variation in efficiency was observed 
for monolith lengths below 500 μm. Despite the efforts to minimize heterogeneity of 
porous network presented in this study, it has been reported that the porous silica 
monolith prepared from the mixture of MTMS and TMOS can exhibit up to 30 % 
variation in the relative standard deviation (RSD) of pore size.78 While the typical pore 
dimensions for both the capillary-integrated monoliths and larger monolith bricks were 
generally consistent with 2.4 μm average pore diameter, the presence of larger through-
pores (>10 μm) was also observed, and are believed to be a significant contributor to 
the high 33% RSD measured for our monoliths. 
Figure 2.9. DLS measurements of 100× diluted blood spiked with E. cloacae, and 
sample collected from the outlet of porous monolith. Broadened peak in the inlet 
sample indicates mixed population of blood cells and small bacterial cells, whereas 
the outlet sample showed significant reduction in large cell population (> 2 µm), as 





To minimize the impact of variable pore morphology on blood lysis efficiency, 
we tested different length of silica monolith capillaries at various flow rates. A study 
of RBC lysis efficiency was conducted using 25× diluted whole blood in TRIS buffer 
at 10 μL/min. In addition to evaluating erythrocyte lysis, the effects of monolith length 
and flow rate on the viability of bacteria were also studied using four bacterial strains 
suspended in TRIS buffer passed through the monoliths using the same experimental 
conditions as the RBC lysis experiments. To evaluate the passage rate and viability of 
individual bacterial strains after monolith passage, cells collected from the chip exit 
were plated and cultured for quantification. The results of these RBC lysis and bacteria 
viability studies are summarized in Figure 2.10. The RBC lysis efficiency was found 
Figure 2.10. Monolith length dependence of RBC hemolysis. 50× diluted blood in 
1× PBS was perfused through monolith-containing capillary segments of various 





to significantly increase for monolith lengths above 1 mm, while intact bacteria passage 
rate remained well above 90% for all monolith lengths tested. 
2.4.4. Mechanical Lysis Mechanism 
Mechanical hemolysis of human erythrocytes within micro pores under 
pressure driven flow was initially expected to be a combination of shear stress-driven 
failure of cell membrane and isotropic membrane tension-induced cell burst. However, 
the absence of peaks at around the through-pore size in DLS result implies that there 
were indistinctive “pinching off” of cells, a separation of small spherical globule from 
the portion of the erythrocytes, which commonly observed in the micropipette 
aspiration study of blood cells in a high flow shear condition.92 Also, a dramatic 
increase in the pressure drop across the monolith segments was observed when less 
Figure 2.11. Passage rates of RBC and viable bacteria strains at different flow rates 





diluted blood perfused. This supports a scenario of mechanical hemolysis caused by 
the built-up isotropic tension within the cell membrane by a complete clogging of a 
pore accompanied with forced deformation of cells beyond its hemolytic threshold. 
The human erythrocyte is a discoid shaped cell with sizes of approximately 2-
3 μm in thickness and 8 μm in diameter, which presents about 40% larger surface area 
compared to the surface area of a sphere of the same volume.93 Combined with its 
viscoelastic cell membrane, consisting of a glycocalyx layer, a lipid bilayer, and a 
membrane integral protein network, RBCs can tolerate a high degree deformation at a 
constant volume and surface area.94,95 However, when the deformation exceeds a 
threshold beyond which the membrane surface area must expand to accommodate 
further deformation, the isotropic membrane tension rapidly increases, and the cells are 
finally observed to lyse when their fractional area expansion reaches a value of 3%, 
corresponding to an isotropic membrane tension of approximately 10 mN/m.96 
When the pore radius is small enough to confine a RBC into a sphero-
cylindrical shape with a given cylindrical radius (𝑟𝑟𝑐𝑐), the volume (Ω𝑝𝑝) and surface area 
(Σ𝑝𝑝) are given by97: 












The corresponding isotropic membrane tension (𝑡𝑡0) of a RBC traveling within 

















Where K is elastic area modulus of RBC membrane (500 nN/μm),98 r is the pore 
radius, and Π is the osmotic pressure at physiological condition (1.3 × 106 Pa at 25 
°C).92 
Based on these expressions, the isotropic tension in the membrane as a function 
of pore radius is presented in Figure 2.11. An RBC can flow freely while deforming to 
fit into a pore when r > rc (where rc = 1.53 μm from Figure 2.11), while flow resistance 
rapidly increases as the pore radius drops below rc and the system exceeds the 
deformation limit where membrane expansion can no longer occur without increasing 
tension. When r < rc, the RBC is forced to stretch further and the membrane tension 
rapidly increases. Finally, at a critical value of r = r* (r*=1.48 μm), isotropic tension of 
Figure 2.12. Isotropic membrane tension of RBC flows in a pore as a function of 
pore radius. Fluidic resistance is negligible when pore radius is within a deformable 
range of RBC, and membrane tension rapidly increases when a pore radius falls 





the membrane reaches 10 mN/m, and mechanical hemolysis occurs. The porous silica 
monoliths presented in this study present an average through-pore radius of 1.2 μm, 
sufficiently smaller than r* to provide high lysis efficiency even in the presence of large 
variance in the pore size distribution.  
2.4.5. High-throughput Bacteria Passage in a Thermoplastic Chip 
In the previous capillary device tests, dilution of blood was required because of 
limited number of pores available for RBC lysis. To extend the capacity of the 
monoliths to whole blood lysis, centimeter-length prismatic monolith rods with 3 mm 
square cross sections were prepared in a PMMA mold, resulting in a cross-sectional 
area increase greater than three orders of magnitude over the capillary devices. Unlike 
the synthesis of porous silica monolith within a fused-glass capillary, the condensation 
reaction between the gel phase and the mold is prohibited due to the absence of silanol 
groups on the PMMA surface. Thus, the periphery of the gel was not constrained, and 
was subjected to volumetric contraction during synthesis, yielding in significantly 
smaller pores at the surface of the resulting monolith rods (Figure 2.12). However, 
because the silica monolith rods were cut to defined lengths using a wafer dicing saw, 
the bulk internal pore structure was exposed for the final monolith bricks. Based on the 
results of length dependence study, 2 mm long monolith bricks were employed for high 
throughput cell lysis and bacteria passage experiments. 
The process for integration of a silica monolith brick into a COP device is 





filling of any narrow gaps between the monolith brick and mating COP substrate while 
infiltrating the monolith surface pores to provide excellent mechanical integrity and 
leak-free flow of whole blood during lysis. During subsequent solvent evaporation, the 
solvated COP successfully formed a permanent bond to the COP chip surface. 
Completed devices were capable of processing > 400 μL of whole blood without losing 
separation efficiency while operating at a flow rate of 10 μL/min. 
Whole blood and whole blood spiked with E. cloacae, L. lactis, and B. subtilis 
were employed to evaluate blood cell lysis and viable bacteria passage through the 
integrated high throughput monolith brick devices. Whole blood was spiked with each 
bacterial strain originally suspended in 1× PBS, and each sample was infused at 10 
μL/min. Individual monolith brick devices were found to be able to process > 400 μL 
of whole blood before exhibiting a significant increase in back pressure, presumably 
due to the entrapment of cell debris within the device. Collected filtrate was directly 
used to analyze RBC lysis efficiency, and diluted 5 times in 1× PBS for bacterial 
passage rate analysis to obtain 30-300 CFU per plate. In these experiments, an average 
Figure 2.13. (a) Multiple monolith bricks prepared by wafer dicing. (b) Magnified 
view of a brick corner. The upper surface was formed by dicing, while the two side 
surfaces were formed by contact with the mold surface. (c) SEM image revealing 
the desired porosity of the diced monolith surface, in comparison to the closed pores 
observed on the surfaces in contact with the mold during sol-gel synthesis. Scale 





RBC lysis efficiency of 99.3 % was achieved, and excellent passage rate averaging 92 
% for all four bacterial strains spiked in whole blood was observed (Figure 2.13). A 
summary comparing viable bacteria passage results for both capillary and high 




Table 2.1. Comparison of intact bacteria passage rate of capillary monolith (1.5 mm 
long) and COP monolith brick (2.0 mm thick) devices. 
Species Capillary device High-throughput device 
 (bacteria only) (whole blood + bacteria) 
E. cloacae 97.4 ± 3.4 % 97.0 ± 5.2 % 
L. lactis 92.7 ± 5.3 % 87.4 ± 0.6 % 




Figure 2.14. RBC lysis efficiency of whole blood in high-throughput devices. Flow 
rate was fixed at 10 µL/min (EC: E. cloacae, LL: L. lactis, BS: B. subtilis). Error 





2.4.6. Serial Operation of High-throughput Monolith Devices 
As shown in Figure 2.13, a single high throughput COP device can successfully 
reduce the population of intact RBCs in whole blood to less than 1 %, however, due to 
the high density of RBCs in whole blood, this level of lysis efficiency still leaves tens 
of thousands of intact blood cells per microliter of effluent. While increased lysis 
efficiency may be possible by extending the length of the monolith, this approach is 
impractical due to the high fluidic back pressure required to pump whole blood through 
a long monolith element. As an alternative, passage of sample through multiple high 
throughput monolith devices was explored. In these experiments, whole blood spiked 
with bacteria was perfused through a first brick monolith device, and the effluent was 
collected and introduced through a second monolith brick chip. A Flow rate of 10 
μL/min was used for both devices to maintain consistent performance, although in 
practice the second device is capable of operating at a higher flow rate due to the 
significant reduction of intact RBC following passage through the first monolith chip. 
During initial testing, it was found that approximately 50% of bacteria were lost 
within the second device during serial operation. This high loss was believed to result 
from the significant reduction in intact blood cells leading to increased interactions 
between bacteria and surfaces within the thermoplastic chips, thus resulting in 
unwanted bacterial adhesion. To maximize bacterial passage during the serial lysis 
experiments, the use of surface passivation to inhibit bacterial adhesion was explored. 
We compared surface passivation for PEG, BSA, and a combination of BSA and Tween 
20. Although RBC lysis efficiency was maintained above 99% regardless of the surface 





Optimal bacteria passage was observed for the case of a combined BSA (5 wt%) and 
Tween 20 (0.05 wt%) solution, which has been reported to optimize surface coverage, 
with BSA providing bulk passivation while Tween 20 fills the small voids that are 
sterically limiting for BSA.18,99 While both PEG and BSA alone did not substantially 
enhance bacteria passage through the second monolith, the BSA / Tween 20 solution 
served as an excellent passivation layer. Using this approach, the RBC lysis efficiency 
was increased to 99.999 % by using two COP devices in series, as shown in Figure 
2.14, while preserving nearly the same number of colony forming units of E. cloacae 
and L. lactis spiked in the initial whole blood sample. 
Figure 2.15. Blood lysis and bacterial separation result from serial operation of two 
monolith. Surface was passivated with BSA/Tween 20. 99.999% of RBC lysis was 
obtained from whole blood while preserving viability of L. lactis and E. cloacae. 






Porous silica monoliths enabled highly efficient mechanical lysis of RBCs 
while passing a range of both gram-positive and gram-negative bacteria without lysis 
or deterioration of their viability. Selective lysis of RBCs is achieved by forcing the 
cells to deform beyond their hemolytic threshold, while the presence of a rigid cell wall 
in bacteria helps to minimize damage to the cells during the passage. The ability to 
integrate millimeter-scale monoliths using a solvent casting technique allows the 
fabrication of robust microfluidic devices with seamlessly integrated monoliths 
presenting large surface areas, greatly expanding the system capacity, with individual 
monolith devices capable of processing up to 400 μL of whole blood without dilution. 
Furthermore, serial processing through multiple monoliths enables the complete lysis 
of all but 0.001% of RBCs in a whole blood sample, together with intact and viable 
passage of nearly 100% of bacteria. The technology holds promise for rapid preparation 
of intact bacteria samples from whole blood or other complex matrices containing 
unwanted cells, with potential for diagnostic applications involving phenotypic 
characterization of isolated bacteria. Finally, we note that synthesis of monoliths in 
both capillary and brick formats is highly scalable using batch processing methods, 
potentially making the resulting devices exceptionally cost effective to fabricate in 





Chapter 3: Lab-on-a-Syringe: Integrated Blood Cell Reducer 
Using Conformal Microfluidics  
 
3.1. Summary 
A porous silica monolith presented in the previous chapter efficiently induced 
mechanical lysis of the blood cells, however, the comparative study of capillary device 
and up-scaled device has revealed that the higher dilution of blood is required for the 
monolith with smaller cross section. Since the mechanical lysis of a cell requires a cell 
to be forced to travel through a pore smaller than its size, resulting in a cell occupying 
a pore until the cell membrane disrupted. Thus, as the number population of cells 
increases, the required number of pores as well as the chance of severe cell clogging 
also increase. Therefore, the performance of porous monolith could significantly 
benefit if a moderate reduction of blood cell can be done prior to the monolith device, 
allowing larger volume to be processed faster and better. In this chapter, the conformal 
integration of thermoplastic microfluidic components onto the cylindrical body of a 
conventional syringe is demonstrated. The hybrid device, designed to combine a small 
volume blood draw with microfluidic plasma isolation using manual syringe actuation, 
is presented as once example for the potential of enhancing conventional clinical tools 
with seamlessly-integrated microfluidic elements capable of adding and simplifying 
assay steps. Here we employ a commercially available cyclic olefin polymer (COP) 
syringe combined with a flexible COP microfluidic substrate to perform blood cell 





(DLD) and the Dean flow focusing (DFF) techniques, without the need for any external 
instrumentation or electronic power source.    
3.2. Introduction 
Thermoplastic microfluidic system benefits from affordable, simple, and rapid 
manufacturing by utilizing traditional fabrication techniques such as micro machining, 
injection molding, or hot embossing.100,101 Unlike the alternative substrates commonly 
used for LoC device including PDMS and paper, rigid nature of thermoplastic materials 
and fabrication techniques limited to flat geometry makes its design also bounded in 
two dimensional. Recently, a new soft lithography technique of thermoplastic called 
“solvent casting” was reported by our group.89 This technique features a viscous 
solution of COP prepared by dissolving COP pellets in a decalin, which can be applied 
similar to PDMS casting process. Once solvent evaporated from the solution, it 
recovers mechanical rigidity and preserves the negative shape of the mold. 
Furthermore, remaining solvent within solidified COP can promotes a permanent 
bonding to another COP substrate. Based on this study, we designed a new smart tool 
called “lab-on-a-syringe”. The lab-on-a-syringe features a microfluidics size-based 
separation device embedded directly onto a conventional syringe, thus integrating a 
sample collection and separation process into a single syringe, one of the most 
commonly used clinical tool.  
In this chapter, we report the direct integration of microfluidic elements onto 
the curved surface of a thermoplastic syringe body, with fluidic interconnects allowing 





approaches are explored. First, a DLD element is integrated into a thermoplastic 
microfluidic substrate to enable blood cell reduction following a blood draw, with 
actuation for both sample collection and plasma separation performed using the 
standard syringe plunger. DLD is a powerful passive particle separation technique that 
sorts particles based on size, with micrometer-level fabrication resolution required to 
distinguish particles in the size range of blood cells or bacteria.44,45 Next, spiral 
microchannel devices employing another passive size separation technique, Dean flow 
focusing (DFF), were integrated into the COP syringes. A unique aspect of this concept 
is that the spiral microchannel geometry is realized by wrapping a straight 
microchannel around the circumference of the syringe body, thus defining the desired 
geometry to develop Dean vortices and achieve particle focusing. The spiral 
microchannel geometry was obtained by simply wrapping two layers of thin film COP 
prepared by solvent casting around the syringe body, with residual solvent drive off 
following permanent solvent-mediated bonding between the COP films and syringe 
body. The resulting integrated devices were used to successfully reduce blood cells at 
the chip outlet. Significantly, efficient separations were achieved using syringe pump 
control as well as manual thumb actuation of the syringe plunger, suggesting that the 
resulting technology may be of particular value for application to diagnostics in highly 





3.3. Materials and Methods 
3.3.1. Materials 
Thermoplastic Zeonor 1020R cyclic olefin polymer (COP) pellets was obtained 
from Zeon Chemicals (Louisville, KY), and Sylgard 184 PDMS was purchased from 
Dow Corning Corporation (Auburn, MI). SU-8 2100 and SU-8 2015 negative 
photoresists were purchased from MicroChem Corporation (Westborough, MA). 
Ethanol (>99.5%), phosphate buffered saline (PBS, tablet), and bovine serum albumin 
(BSA, powder) were purchased from Sigma-Aldrich (St. Louis, MO). Decalin (cis + 
trans, 98%) was purchased from Alfa Aesar (Haverhill, MA). 4.5 mm thick PMMA 
sheets were purchased from US Plastics Corporation (Lima, OH). NutriChef vacuum 
sealer was purchased from PyleUSA Incorporation (Brooklyn, NY). Fluorescent-
labeled 1 µm and 8 µm diameter microspheres were purchased from Microsphere-
Nanospheres (Cold Spring, NY), and 6 µm diameter fluorescent-labeled particle was 
purchased from Thermo Fisher Scientific (Waltham, MA). 1 mL COP syringes were 
purchased from Merit Medical OEM (Salt Lake City, UT). The body of each COP 
syringe was approximately 8 cm long, with an outer diameter of 1.0 cm. 
3.3.2. Thin Film Thermoplastic Patterning by Solvent Casting 
Thin COP film with molded microfluidic features were achieved through 
application of a thermoplastic solvent casting process, which enables the fabrication of 
pliable solvent-laden thermoplastic substrates containing high resolution microchannel 
and other microscale structures.89 First, the desired microfluidic feature was patterned 





PDMS soft lithography. After fully curing the PDMS, a solution of solvated COP, 
prepared by mixing COP pellets with decalin by 27:73 weight ratio, was poured on the 
PDMS mold and covered with another piece of flat PDMS to obtain a patterned thin 
film of COP upon curing. Decalin was gradually removed from the COP solution 
through the bulk PDMS by placing the mold on a custom vacuum curing chuck for 10 
h at room temperature. Once cured, the patterned COP film was peeled from the PDMS 
mold, then subjected to device bonding. A flat film of COP was prepared in a similar 
procedure, by spin coating solvated COP on a 10 cm silicon wafer at 500 rpm for 55 s, 
followed by curing on 60 °C hotplate for 4 h while covered with an unpatterned layer 
of PDMS.  
3.3.3. Integration onto a Commercial COP Syringe 
The syringe integration of thin film COP patterned with DLD microposts is 
described in Figure 3.1. First, fresh COP surface was prepared on COP syringe by 
mechanically polishing outer surface to remove protective coating and labels, and 
manually drilled to open vias connecting syringe chamber to microfluidic device. Lab-
Figure 3.1. Process of fabrication of thin film COP microfluidic device and 





on-a-syringe device was completed by exposing outer surface of COP syringe to a 35 
vol% decalin/ethanol solution, stacked with a patterned COP film and a flat COP film, 
then sealed in a plastic zip bag using the food vacuum sealer to formulate intimate 
contact between films and syringe. Bonding was completed by thermally curing it in a 
60 °C oven for 10 min. After curing, the device was rested overnight to evaporate 
excess solvents. Prior to use, microchannels were passivated with 5 mg/mL BSA in 1× 
PBS solution. 
Integration of thin film microfluidic channels for DFF is done in a similar 
manner. First, two layers of COP film patterned with DFF designs were prepared by 
solvent casting method as described above. Then, a main channel layer consists of main 
channel, gutter channel, inlet port, and two outlet ports was aligned perpendicularly to 
a COP syringe, and stacked with a side channel layer which consists of side channels 
and alignment marks. Stacked thin films then wrapped around the syringe barrel 
yielding spiral geometry for DFF separation. Bonding was completed by the same 
method.     
3.4. Results and Discussion 
3.4.1. Lab-on-a-Syringe Device Fabricated via Solvent Casting Technique 
The lab-on-a-syringe designs explored in this work are composed of a thin film 
DLD device and a thin film DFF device fabricated by thermoplastic soft lithography 
technique in a 200 µm thick COP substrate and conformally bonded to the body of a 
COP syringe. Figure 3.2 describes the precision of solvent casting technique. The DLD 





were successfully patterned into solvated COP from an SU-8 mold and PDMS negative 
mold, achieving the initially flat substrate to be wrapped around a 1 mL syringe body. 
The DFF design consists of main channel layer and side channel layer. Main channel 
layer includes an 8 cm-long straight main channel with a cross section of 100 µm height 
and 40 µm width and a gutter channel with a cross section of 100 µm height and 300 
µm width. Side channel layer consists of 9 side channels aligned perpendicularly to 
main channel direction and with 2 mm spacing and a cross section of 10 µm height and 
50 µm width. Compared to the DLD design which benefits from negligible effect to 
separation performance caused by the curved surface of syringe, DFF design is only 
functional when the patterned COP films are wrapped around the cylindrical body of 
syringe. A straight channel in a main channel layer is naturally forms a spiral when 
Figure 3.2. SEM images of SU-8 mold and replica fabricated via solvent casting 
technique. (a) SU-8 mold of a DLD device and (b) COP replica. (c) SU-8 mold of 





wrapped on, allowing the Dean vortices to appear within a microchannel which can 
induce DFF-based separation of particles.    
 The vacuum chuck used in this study was specially designed to direct solvent 
removal through the bottom side of a PDMS negative mold by utilizing the gas 
permeable nature of PDMS. Solvent removal in the vacuum chuck not only minimized 
unwanted distortion of PDMS from solvent absorption, but also improved casting 
process by removing air voids through PDMS, obtaining high quality replica with tens 
of micron feature size (Figure 3.2). Unidirectional removal of solvent also enabled 
cured COP films to retain the solvent in the side opposite to the vacuumed side, which 
promotes the bonding to another COP film or a COP syringe surface through the same 
mechanism of solvent-aided thermoplastic bonding.       
Figure 3.3. Operation scheme of the lab-on-a-syringe device. (a) A device, prefilled 
with diluent buffer, is used to (b) draw blood from a patient. (c) Manual gentle 
agitation is done to assure homogeneous mixing, then (d) needle is replaced with a 
sealed cap to direct flow into the DLD device. (e) Illustration of blood cell reduction 





Integration of microfluidic elements onto a COP syringe was realized by the 
solvent-mediated bonding by utilizing residual decalin in a cured COP film and the 
subsequent thermal curing. To formulate an intimate contact between two bonding 
interfaces, we utilized the food vacuum pump and a sealing bag so that the pressure can 
be evenly applied on a three-dimensional substrate. Because both the microchannel 
substrate and syringe were manufactured from COP, no plasticizing or cracking of the 
syringe was observed.   
3.4.2. Size-Based Separation by On-syringe Deterministic Lateral 
Displacement 
Operation of the lab-on-a-syringe device is straightforward as described in 
Figure 3.3. After drawing blood directly from a patient into the syringe containing 
buffer, the needle is replaced with a cap and the plunger is depressed to drive sample 
through the attached microfluidic device. Processed blood with reduced cell population 
is routed to a collection port, while displaced stream of blood cells returns to the syringe 
through extra holes to be sequested behind the syringe plunger. Flow rates up to 100 
µL/min were achieved by manual thumb press, with no degradation of cell separation 
performance observed in this range.  
Separation performance was first confirmed using synthetic microparticles. The 
micropost array in a DLD device was designed to have a critical size of separation of 
2 µm. Within a micropost array, an incoming flow repeatedly bifurcates at every 
micropost, forming a complex flow network along the array. For a particle smaller than 





exhibits “zigzag” pattern along the flow direction (Figure 3.4.). On the other hand, a 
particle larger than the critical size is constantly deflected by the array of offset posts 
within DLD device, forcing the larger particle displaced laterally at every micropost. 
As a result, its trajectory along the micropost array exhibits a straight, bumping pattern. 
Thus, a flow initially mixed with two particles of different sizes can form two separate 
particle streams at different position at the channel cross section, allowing size-based 
particle separation. Separation performance of the DLD design was first examined 
using 1 µm, 6 µm, and 8 µm diameter microparticles by comparing number population 
of particles before and after perfused through the DLD device, and the critical diameter 
was 2 µm. As shown in Figure 3.5, no significant difference in particle population was 
found for 1 µm microparticles, while up to 92.4% particle reduction was observed for 
larger particles collected at the particle-free outlet of the device.                
Figure 3.4. Optical image of DLD array. Different particle paths were observed in 
flat DLD device when fluorescent beads tested; (middle) 1 µm particles proceed in 





When applied to blood, size-based separation was impacted by two major 
issues. First, increased frequency of cell-to-cell collision induces chaotic deflection, 
which counteracts the desired lateral migration behavior within the array. Second, the 
small gaps required for proper separation of blood cells, together with the high number 
of cells in whole blood results in rapid clogging of the gap near inlet even after treating 
the surfaces to reduce non-specific binding, thereby decreasing the efficiency of the 
array dramatically. To achieve useful separations, significant dilution of the initial 
blood sample was found to be required for the syringe-integrated DLD device. As 
shown in Figure 3.6, higher dilution level resulted in improved performance, with tup 
to 80% separation efficiency achieved for 500× diluted blood. While this level of 
separation offers potential for applications requiring a moderate reduction in blood cell 
count, the broader utility of this approach is limited by the need for high dilution level, 
leading to lower analyte concentration and increasing separation time scale due to the 
larger sample volumes involved.  
Figure 3.5. Separation of fluorescent polystyrene particles by diameter (upper 
row) solution before processing through a lab-on-a-syringe device, (bottom row) 





3.4.3. Size-Based Separation by On-syringe Dean Flow Focusing  
To limit the need for sample dilution observed for the case of on-syringe DLD 
separation, we next explored an alternative microfluidic separation method based on 
Dean flow focusing (DFF), also called spiral microfluidic separation. DFF is a unique 
particle focusing phenomena observed in a curved microchannel. As fluid flows along 
the length of a curved microchannel, the parabolic flow velocity profile within the 
channel is disrupted, leading to the formation of a secondary circulatory flow called 
Dean vortex. The formation of Dean vortex is caused by the increased contribution of 
centrifugal force from the curved geometry, and the resulting Dean flow appears 
perpendicular to the primary flow direction. The intensity of the Dean vortex is 









Figure 3.6. Blood cell reduction vs. blood dilution level. Optical images of cell 
reduction of 500× diluted blood. (b) Before and (c) after processed through the 





Where Dh is the hydraulic diameter of microchannel, Rc is the radius of 
curvature of channel path, ρ is the density of fluid, U is the linear velocity of flow, µ is 
the dynamic viscosity of fluid. At sufficiently high Dean number, two counter-rotating 
vortices appear exert a net force on particles within the channel. Due to this force, 
particles can be rapidly focused into size-dependent equilibrium positions within the 
primary flow. Compared with other hydrodynamic separation methods, this focusing 
behavior can be achieved very rapidly.  
The patterning of a curved flow path with an appropriate radius of curvature is 
the most essential requirement for DFF separations. Significantly, conventional 
disposable syringes with outer diameters around 1-2 cm can provide an adequate 
curvature for micron-scale particle separation using the DFF method, opening the 
possibility of performing blood separations by taking advantage of the cylindrical 
geometry of the syringe itself. In this concept, a straight microchannel is wrapped 
around the outer circumference of the syringe body, allowing particles to be focused at 
specific radial positions within the channel. Implementation of this concept requires 
careful design of the microchannel to ensure efficient separation. The channel length 
required for achieving inertial focusing in a straight microchannel (Lf,st) and DFF in a 










Where h is the height of channel, Umax is the maximum linear velocity of flow, 
Dp is the diameter of particle, fL is the dimensionless lift coefficient, and f is the 
coefficient for Dean focusing. Empirically found value of the coefficient for Dean 
focusing varies from 0.2 to 1.0. Thus, for given channel cross section and target size, 
the rest of DFF channel dimensions can be found from this equation. Channel 
dimensions of 40 µm width and 100 µm height were selected for main channel and 50 
µm width and 10 µm height were selected for side channels assuming a Dean number 
of 1 at imposed flow rate of 100 µL/min flow, with the channel wrapped around a 
commercial 1 mL COP syringe with outer diameter of 1.0 cm. Using the unique 
integration method, a spiral flow path from an 8 cm-long straight microchannel was 
successfully realized (Figure 3.7)   
Figure 3.7. Lab-on-a-syringe device with DFF microfluidic separator. Inlet 
connection is made at the front side of the syringe, and waste outlet was drilled in 
syringe body to enable the recollection of processed waste into the secondary 
chamber behind plunger tip. Secondary chamber is sealed with an Viton O-ring (red 





The lab-on-a-syringe device with integrated DFF channel was characterized to 
evaluate blood separation efficiency over a range of conditions. The fabricated device 
was able to process 25 times diluted whole blood with >89% separation efficiency at 
all tests, showing significantly improved separation at low dilution level compared to 
the DLD-integrated lab-on-a-syringe device. Blood cell separation tests are 
summarized in Figure 3.8.  Improved separation of DFF method is contributed from 
Dean vortices, which plays an essential role in the migration of particle and the 
formation a focused particle stream. As previously discussed, cell-to-cell collision is a 
Figure 3.8. DFF-based separation of 25× diluted whole blood operated by syringe 
pump and manual thumb pressure. N=3 for 50 µL/min flow rate, and N=2 for other 





typical disturbance observed in low dilution level blood or whole blood. Continuous 
separation of particles in a microfluidic system typically necessitate a focused stream 
of particle to enable the collection of particle-deficient portion of the flow by installing 
a spatially separate outlet at far from the focused particle flow. Increased inter-cell 
collisions inevitably broaden the particle stream and shrink the particle-deficient zone, 
making the spatially isolated sample collection more difficult. For the DFF technique, 
the equilibration points are found at asymmetric position on channel cross section 
because the Dean vortices constantly recirculating perpendicular to flow direction 
make possible equilibration points for straight microchannel unstable. Therefore, the 
focused particle stream in spiral microchannel tends to be located far away from one 
side of channel, allowing more efficient spatial flow collection as well as higher 
tolerance to the broadening effect on focused cell stream at lower dilution level. High-
throughput operation is another advantage of DFF technique. Reynolds number-
dependency of Dean number indicates that at higher flow rate, the intensity of the Dean 
vortices also increases. Conventional hydrodynamic separation techniques are based 
upon a premise that the convective force of the flow is negligible to the diffusive force, 
hence it requires very low Reynolds number. At higher feed rate, the assumption of 
negligible convective force becomes not valid, and the hydrodynamic behavior 
deviates from theoretical expectation. DFF method, however, requires relatively higher 
Reynolds number to induce Dean vortices, and can tolerate much higher Reynolds 
number up to the scale of one hundred whereas the most of conventional hydrodynamic 
separation techniques only valid for Re < 10. As shown in Figure 3.8, the DFF lab-on-





rate of 50 µL/min and 100 µL/min, respectively. When the lab-on-a-syringe was 
manually actuated the plunger with thumb press, it showed the maximum separation 
efficiency of 97.1%, presenting its potential toward the point-of-care operation for the 
tasks require moderate removal of blood cells, or more importantly, for the needs of 
preparing the collected sample at resource-poor environments.  
3.5. Conclusions 
In this study, we presented a new smart tool hybridized with a microfluidic size-
based separation device fabricated by a thermoplastic soft lithography technique called 
“solvent casting”. Micron-scale features were successfully pattered onto thin films 
COC, then integrated onto a common thermoplastic syringe, enabling straightforward 
operation from sample collection and preparation within a syringe. Solvent casting 
enabled the fabrication of microfluidic devices onto non-flat substrate, opening up a 
various way to hybridize microfluidic platforms with everyday items. DLD and DFF 
microfluidic size-based separation methods were presented, and excellent separation 
efficiency above 89% for 25× diluted blood was observed for all DFF devices, with the 
aid of syringe pump as well as with a simple thumb press, presenting promising 






Chapter 4: 3D-Printed Micro Hydrocyclones for High-
Throughput Particle Separation 
 
4.1. Summary 
In this chapter, we report the 3D-printed micro hydrocyclone (µHC), enabling 
high-throughput separation of micron-sized particles from liquid flow at high flow rates 
the order of tens milliliters per minute. The application of stereolithography-digital 
light processing (SLA-DLP) 3D printing successfully realized the complex 
microfluidic design of µHC in hundreds of microns scale. The resulting device can 
efficiently separate sub-10 µm microparticles from milliliters of solution in a few 
seconds. Furthermore, SLA-DLP printing offers control over device design with 
arbitrary 3D dimensions, enabling fundamental investigations of hydrocyclone physics 
and performance that cannot be easily achieved by traditional fabrication methods. 
4.2. Introduction 
Solid-liquid separation is the most foreground fundamental for many biological 
and clinical processes. In the clinical laboratory, isolating a certain type of cell from a 
clinical specimen or removing cellular components from blood greatly improve the 
accuracy of diagnostic tests. Bioreactors for large-scale drug production or biomass 
production necessitate the enrichment step to isolate a target substance from the 
mixture of feed solution, byproducts, etc. 
Conventionally, solid-liquid separation in those area have been achieved via 





operation; centrifugal force and size-based retention, respectively.102,103  However, 
these approaches present major drawbacks such as lengthy operation, degradation of 
performance by biofouling, and risks of cellular damage, which limits their utilities 
especially in clinical applications due to sensitive natures of biological specimen.104–
106 As the lab-on-a-chip (LoC) platform has become more and more important with 
advances in microfabrication techniques and microfluidics, the separation technologies 
also have been developing toward the goals of miniaturization, on-site operation, short 
turnaround time. Microfluidic-based separation techniques are generally categorized 
into active separation and passive separation. Active separation techniques utilize 
external forces such as electric field, magnetic field, or acoustic wave, whereas passive 
separation techniques entirely hydrodynamic forces and microstructure.40,42 
Compared to various active separation techniques reported in the field, no use 
of external forces offers a strong advantage to passive microfluidic separation 
techniques toward more complete LoC system. Filtration and size-based sorting are 
two major strategies to formulate passive solid-liquid separation. Filtration through an 
integrated membrane or a microporous structure formed within the device is a 
straightforward mechanism, however it still suffers from the same inherent problems 
of macroscale filtration such as bio-fouling and narrow dynamic range of operation. 
Size-based sorting techniques including inertial focusing, deterministic lateral 
displacement (DLD), pinched flow fractionation, and Dean flow focusing induce the 
lateral migration of solid particles within a continuous flow by balancing hydrodynamic 





because the hydrodynamic force balance becomes extremely difficult to achieve when 
flow is not laminar. 
Hydrocyclone is a very powerful solid-liquid separation technique utilizing the 
centrifugal force generated from its unique geometry and flow profile. Taking 
advantages of simple and extremely high throughput separation, macro-scale 
hydrocyclone has been an essential separation device in various industrial area 
including mineral dewatering,107,108 catalyst recovery,109 and water treatment.110 
Despite the long history of hydrocyclone, fundamental understanding about the solid-
liquid separation within hydrocyclone is still limited to empirical knowledge and 
numerical simulation of certain designs, mainly due to its complex internal structure 
and highly turbulent flow appeared during operation. Additionally, the technology has 
not been broadly adapted to bioseparation area, because relatively small sample 
volumes associated with clinical specimens or pharmaceutical batch process is far less 
than the typical feed volume required for conventional hydrocyclone, which is 
hundreds to thousands of liters. Recently, miniaturized hydrocyclones to centimeter 
scale have shown the promising potential of micro hydrocyclone (µHC) as a new 
solution for isolating micron-sized object from a limited volume of feed, making it 
suitable for various biological processes.111  
However, µHC still poses two major challenges. First, µHC can exhibit 
different separation behavior compared to conventional hydrocyclone because of 
increased Brownian motion which counteracts the directed migration of a particle, or 





the complexity of the design. Geometry of hydrocyclone represented by two famous 
models, Rietema hydrocyclone and Bradley hydrocyclone, generally consists of a 
cylinder connected to a conical bottom, a tangentially connected inlet, two axially 
attached outlets at the top and the bottom of the device, and a smaller cylinder 
protruding from the top of the device.112–114 Thus, realizing its three dimensionally 
interconnected structure in micron scale is almost impossible for conventional 
microfabrication techniques. 
With recent advances in additive manufacturing such as 3D printing, a new 
pathway was found toward the realization of unconventional microfluidic designs. 
Stereolithography coupled with digital light processing (SLA-DLP) 3D printing 
technique utilizes the photosensitive liquid resin and the digital micro mirror device 
that can generate a series of two-dimensional photomasks by slicing a three-
dimensional design. By constructing each layer vertically, SLA-DLP printing can 
rapidly produce various unconventional microfluidic devices with tens of micron to 
hundreds of micron-sized features.115,116  
In this study, we report the first successfully realized single millimeter-sized 
µHC device with a hundred micron-scale feature sizes, fabricated by SLD-DLP 3D 
printing technique. Prepared devices successfully separated microbeads from milliliters 
of suspension within only a few seconds, suggesting a promising potential for the 
ultrafast separation of clinically relevant samples. Based on theoretical understanding 
of the forces exerted on a particle within a flow, advanced µHC design was suggested 





4.3. Materials and Methods 
4.3.1. Preparation of Micro Hydrocyclones via SLA-DLP 3D Printing 
A Bradley hydrocyclone model was selected as a design guidance to prepare a 
1.5 mm diameter µHC for this study114,117,118, with parameters adjusted for optimal 
printing quality (Table 4.1).  
A 3D stereolithography (STL) file of µHC was prepared in SolidWorks 
(Dassault Systems Corporation, Waltham, MA). A coned port connector was also 
integrated for fluidic interfacing, enabling direct connection to a syringe for manual 
actuation of this device. A µHC STL file was then moved to the printing computer to 
convert into layered masks, and it was printed at 25 µm z-step resolution using an 
EnvitionTEC perfactory 4 SLA-DLP tool (Envisiontec Inc., Dearborn, MI). Printed 
devices were cleaned with isopropanol to remove any uncured resin, followed by the 
secondary UV curing in an Otoflash post curing light pulsing unit (Envisiontec Inc., 
Dearborn, MI) to complete photopolymerization process.    
4.3.2. Computational Fluid Dynamic Simulation of Micro Hydrocyclone 
To validate µHC design and find proper operational condition, the flow path for 
each µHC designs were simulated using COMSOL Multiphysics software (COMSOL 
Inc., Burlington, MA) and ANSYS Fluent (ANSYS Inc., Canonsburg, PA). We 
simplified fluidic ports in design files for the numerical simulation to minimize the 
calculation loads, while the internal geometry was drawn identically. For COMSOL, 
the model was imported in Cartesian coordinate system and meshed via COMSOL’s 





imported in Cartesian coordinate system, and custom meshed with tetrahedral mesh to 
obtain 450k, 880k, 2 million, and 7 million elements. Fluid was defined as 
incompressible water for both software. For time-independent turbulence simulation 
on ANSYS, the realizable κ-ε model and enhanced wall function was used. Calculation 
was conducted by choosing the semi-implicit pressure linked equation (SIMPLE) as 
pressure-velocity coupling algorithm with higher-order quadratic upwind interpolation 
(QUICK) as density interpolation scheme. To account highly rotational flow within 
µHC, the Pressure staggered option (PRESTO) was chosen as a pressure interpolation 
scheme. Three feed rates from 5 mL/min to 40 mL/min was calculated until it 
converged to residual criteria 10-5.   
4.3.3. Size-Based Particle Separation Procedure 
Solid-liquid separation of µHC was determined by infusing an aqueous solution 
containing silica microparticles purchased from Microspheres-Nanospheres (Cold 
Spring, NY). A µHC was connected to 20 mL syringe via F-120 fluidic fitting (IDEX 
Health & Science, Oak Harbor, WA), and flow rates were controlled by the Harvard 
PHD 2000 syringe pump (Harvard Apparatus, Holliston, MA). Perfused solutions were 
collected separately at overflow exit and underflow exit, then analyzed using Nikon 
LV-100 optical microscope (Nikon Instrument Inc., Melville, NY) and ImageJ 





4.4. Results and Discussion 
4.4.1. Basis of Micro Hydrocyclone 
Hydrocyclone is a powerful solid-liquid separator widely used in mineral 
processing and petroleum cracking,119,120 even in water treatment.121 Hydrocyclone 
separation can be achieved via formation of spiral flow path within its body, exerting 
centrifugal force to a solid particle traveling along this swirling flow. Unlike many 
hydrodynamic separation techniques, hydrocyclone operates at transient and 
turbulence flow regime. Although it is difficult to analyze the relationship between 
design parameters, operational condition, and to estimate the particle separation 
performance of hydrocyclone due to a complex behavior of turbulence flow, 
empirically established hydrocyclone models and observations have been a reasonable 
guidance for designing a new hydrocyclone in various size scale. In this study, we 
selected Bradley hydrocyclone model, first suggested in 1960s, to build 1.5 mm main 
diameter hydrocyclone as shown in Table 4.1.114 
Hydrocyclone can be divided into three major parts; the cylindrical part 
consisting the upper body of hydrocyclone, conical part consisting the lower body of 
hydrocyclone, and the vortex finder within a cylindrical part as denoted in Figure 4.1. 
Table 4.1. Design guideline for Bradley hydrocyclone and dimensions of µHC 






When feed flow enters the top of hydrocyclone through a tangentially attached inlet, it 
flows along the cylindrical wall naturally forming a rotational flow (Figure 4.2). Due 
to the presence of vortex finder, entering flow cannot directly proceed to the overflow 
exit, and it keep flows along spiral direction. If inlet flow exceeds a certain velocity, 
this spiral flow path develops further in the axial direction toward the underflow outlet. 
If particle density is greater than that of the fluid, particle migrates toward the 
hydrocyclone wall by centrifugal and buoyant forces. Finally, particles near the 
hydrocyclone wall exit through the underflow, while the overflow is depleted of 
particles.  
Figure 4.1. (a) cut-through view of µHC and a 3D-printed device. (b) Design 
parameters for hydrocyclone: primary diameter (Dc), vortex finder length (L), 






4.4.2. Theoretical Analysis of Particle Separation in Hydrocyclone 
Although the particle behavior within a hydrocyclone cannot be analytically 
solved, balancing the major forces exerted onto a particle can provide an insight for 
optimizing hydrocyclone design and operational conditions. As denoted in Figure 4.2., 
particle traveling along the spiral path experiences three major forces; centrifugal force, 
drag force, and buoyancy force. Centrifugal force caused by rotation flow along axial 










Where 𝑣𝑣𝑠𝑠 is the tangential velocity of particle, r is the radius of hydrocyclone, 
𝜌𝜌𝑃𝑃 and 𝐷𝐷𝑃𝑃 are particle density and diameter. Drag force assuming Stoke’s flow can be 
expressed as below:122  
𝐹𝐹𝐷𝐷 = −3𝜋𝜋𝐷𝐷𝑝𝑝𝜇𝜇𝑣𝑣𝑟𝑟 
Figure 4.2. Trajectory of a particle within a hydrocyclone and applied forces on a 





Where µ is the fluid viscosity and 𝑣𝑣𝑟𝑟  is the migration velocity in radial 
direction. By considering centrifugal force acting as a gravitational force on a particle 
in radial direction, buoyancy force can be expressed by considering the fluid mass 










Where 𝑉𝑉𝑝𝑝 is the volume of particle, and 𝜌𝜌𝑓𝑓 is the fluid density. 
When hydrocyclone operates at steady-state, the force balance can be achieved 
between three major forces, then the radial velocity can be expressed as a function of 
density difference between particle and fluid, size of the particle, diameter of 
hydrocyclone (𝐷𝐷𝑐𝑐), which is twice the radius of hydrocyclone (r), and the tangential 
velocity:122 




 Based on this equation, tangential velocity, density difference between particle 
and fluid, particle diameter, and diameter of µHC play an important role in the solid-
liquid separation in µHC. In design perspective, both tangential velocity and diameter 
of µHC are controllable, by either narrowing down the flow path area or scaling down 
overall system dimensions. Although it has recently reported that the minimum feature 
size at the order of ten micron can be achieved using the custom resin of 
polyethyleneglycol diacrylate (PEGDA) in a lab-made SLA-DLP printer,115 those size 
range was not achievable in the equipment and the commercial resin used in this study. 





tangential velocity was demonstrated in the last section. If possible, controlling other 
key geometries found from analytic model could benefit the separation of biological 
targets such as red blood cell. First key geometry is the length of vortex finder.  
Elongated vortex finder will allow an entering particle to stay longer in spiral flow path 
before it meets the overflow outlet, yielding increased radial migration of a particle. 
Another key geometry is the main diameter of the hydrocyclone. Although it has never 
demonstrated, it is generally suggested that smaller main diameter of hydrocyclone will 
be able to separate smaller size particle better at the same inflow setting.        
4.4.3. CFD Simulation of Bradley Micro Hydrocyclone 
As described in previous section, CFD calculation was demonstrated to validate 
the development of spiral flow path within µHC at each operation condition. First, 
COMSOL simulation was demonstrated to provide initial guidance at low precision 
simulation setting, then full study was employed by ANSYS Fluent at higher degree 
interpolation schemes and algorithm for highly rotational turbulence flow within µHC.  
Figure 4.3. Flow path of µHC operating at different inlet velocities simulated by 
COMSOL multiphysics. 1 m/s, 5 m/s, 10 m/s inlet velocities correspond to 4 





As shown in Figure 4.3, insufficient development of spiral flow was found at 
low inlet velocity, whereas higher than 5 m/s inlet velocity clearly showed the 
development of swirling flow. Based on COMSOL results, the particle separations 
were demonstrated at 5 mL/min, 20 mL/min, 30 mL/min, and 40 mL/min.  
ANSYS Fluent study showed very similar flow path when calculated at 
convergence criteria of 10-5 for 450k to 7 million mesh elements. As shown in Figure 
4.4, µHC operates at 10 m/s inlet velocity exhibits rotational flow throughout the entire 
body as expected, and also exhibits bidirectional flow along axial center (Figure 4.4(c)) 
presented as positive vertical velocity at the upper side of µHC and negative vertical 
velocity at the lower side of µHC. The presence of bidirectional flow together with 
Figure 4.4.  (a) Tangential velocity at the center of the modified Bradley µHC 
operating at 10 m/s inlet velocity. (b) Vertical velocity profile at the same velocity. 





highly rotational flow indicates that the flow exiting through overflow exit will be 
particle deficient due to particle migration outward in radial direction.  
4.4.4. High-Throughput Particle Separation in Modified Bradley 1 Micro 
Hydrocyclone 
To compare with simulation results, micro particle separation was demonstrated 
using 3.7 µm and 7.9 µm diameter silica particles. Particle suspension tests perfused at 
different inlet velocity were well-agreed with CFD results and expectation based on 
analytic model, showing lesser particle population at the overflow compared to the 
underflow at higher flow rates. Similar trends were also found when larger particle is 
used, showing almost complete separation of 7.9 µm microsphere at 40 mL/min feed 
rate. Assuming a common blood collection process, a volume of standard blood 
collection tube (6 mL) can be processed less than 10 s, or less than a minute if a 
moderate dilution is necessary. To analyze the separation efficiency, we defined the 
degree of separation by the number population difference between the overflow (No) 
and underflow exits (Nu):  




Degree of separation plotted for different particle size and feed rate is 
summarized in Figure 4.6, showing maximum degree of separation of 0.89 and 0.94 






Figure 4.6. Separation efficiency of modified Bradley µHC at different volumetric 
flow rates. 
Figure 4.5. Separation of silica microspheres (a) 3.7 µm diameter particles and (b) 
7.9 µm diameter particles infused at different flow rates. Samples were collected 





4.4.5. Enhanced Particle Separation of Modified Bradley 2 Micro 
Hydrocyclones 
As discussed in the previous section, analytic approach to understand particle 
migration revealed two design strategies to improve particle separation, increasing the 
tangential velocity and the overall miniaturization of the system. Due to the lower limit 
in the printable size of the equipment used in this study, design adjustment was only 
made to narrowed down the gap distance between the vortex finder and cylindrical wall 
by 50 µm (Bradley 2 µHC), hence increasing tangential velocity within this gap by 
44% at the same volumetric flow rate tested for our initial design (Bradley 1 µHC). As 
expected in the analytic model, increased inlet velocity resulted in increased degree of 
separation compared to our initial design, as shown in Figures 4.7 and 4.8. Although 
the actual particle-flow interaction within µHC nor particle behavior in a miniaturized 
system cannot be simply described by the analytic equation, the result implies that the 
force balance analysis can provide a useful approach for design improvement and 






Figure 4.8. Comparison of separation performances between two different µHC 
models. (a) Data for 3.7 µm particle and (b) for 7.9 µm particles. Modified Bradley 
2 µHC showed higher degree of separation at all flow rates above 20 mL/min, with 
maxima of 0.882 and 0.978 for 3.7 µm diameter and 7.9 µm diameter particles, 
respectively. 
Figure 4.7. (a) Separation of 3.7 µm silica microspheres in the Bradley 2 µHC (b) 
Separation of 7.9 µm silica microspheres in the Bradley 2 µHC, at different flow 






The application of SLA-DLP printing to complex microfluidic designs such as 
the µHC platform provides a promising route to the realization of unconventional 
microfluidic systems. The present work successfully demonstrated rapid and efficient 
separation of single-micron sized particles, enabling separation of small volume 
samples suitable for clinical use. Based on theoretical analysis, it successfully shown 
that performance can be improved even with minor design modification, which 










In this chapter, the fabrication of on-chip displacement pumps integrated into 
thermoplastic chips is explored as a simple and low-cost method for achieving precise 
and programmable flow control for disposable microfluidic systems. The displacement 
pumps consist of stainless steel screws inserted into threaded ports machined into a 
thermoplastic substrate which also serve as on-chip reagent storage reservoirs. Three 
different methods for pump sealing are investigated to enable high pressure flows 
without leakage, and software-defined control of multiple pumps is demonstrated in a 
self-contained platform using a compact and self-contained microcontroller for 
operation. Using this system, flow rates ranging from 0.5 - 40 μL/min are demonstrated. 
The pumps are combined with on-chip burst valves to fully seal multiple reagents into 
fabricated chips while providing on-demand fluid distribution in a downstream 
microfluidic network, and demonstrated for the generation of size-tunable water-in-oil 
emulsions. 
5.2. Introduction 
5.2.1. Fluid Actuation of Microfluidic System 
Fluid actuation is an inherent and essential requirement for the operation of all 
microfluidic systems. For devices designed to operate in conventional laboratory 





flexibility in system design, with numerous pump technologies available for achieving 
a wide range of volumetric flow rates. For example, syringe pumps are nearly 
ubiquitous in many microfluidics laboratories, with fluid contained in an external 
syringe body introduced into the microfluidic system based on computer-controlled 
displacement of the syringe plunger through a motorized lead screw. However, the use 
of off-chip pumps can be problematic for applications where system cost, size, and 
complexity are important considerations, such as resource-limited settings, field 
environments, or small clinics where access to traditional laboratory infrastructure and 
other resources can be highly constrained. While pump cost can be reduced, for 
example through the use of additive manufacturing to realize open-source syringe 
pumps for a fraction of the cost of commercial options,123–125 the relatively large 
footprint and added system complexity introduced by off-chip pumps represent distinct 
disadvantages. Similarly, the need for world-to-chip interfacing between external 
pumps and on-chip microchannels remains a key challenge for the realization of 
practical disposable microfluidic assays,126 particularly when reagents need to be stored 
off-chip, loaded into pumps, and introduced to a chip through large dead volumes 
typically associated with interface fluidics. 
5.2.2. Micropump Technologies 
The direct integration of pumps into microfluidic systems has been the focus of 
significant research attention over many decades, and offers a path to overcome these 
limitations. Passive pumping techniques including capillary127–131 and gravity132,133 
based actuation have been used to induce fluid flow in microfluidic devices without the 





for applications demanding automated and zero-power operation. However, passive 
actuation cannot control flow rates with arbitrary time profiles, and is limited to 
microfluidic systems with exceptionally low flow resistance. Integrated micropumps 
employing active actuation can overcome these issues using driving mechanisms such 
as piezoelectric, thermos-pneumatic, phase change, electrostatic, electrokinetic, 
electrochemical, or electromagnetic actuation, as summarized in various micropump 
technology reviews.134–137 In the case of piezoelectric, electrostatic, and 
electromagnetic actuation, the use of active pumping can add significant complexity 
and cost to the microfluidic system due to the need for coupling discrete actuation 
elements with on-chip microchannels. Electrokinetic actuation can be an effective 
pumping method, but imposes strict requirements on the working fluid and material 
system used for microchannel fabrication, and is thus limited in its range of application. 
Transduction mechanisms including phase change, thermos-pneumatic, and 
electrochemical actuation have also proven to be attractive for specific applications, 
although with relatively slow response times as well as low flow rates and pressures 
that may be generated. Furthermore, in all of the above cases the need for world-to-
chip interfacing for reagent delivery remains.  
More recently, several integrated pumping mechanisms for microfluidic 
devices based on manual actuation have been reported. Vacuum driven pumping that 
takes advantage of the high gas permeability of elastomeric polydimethylsiloxane 
(PDMS) has been explored for integrated microfluidic systems,138,139 with either 
placement of an evacuated PDMS pump element at the microchannel outlet139 or 





a PDMS layer138 used to establish a pressure gradient. Similarly, a variety of elastomer-
based pumps designed for simple manual actuation have been reported,138,140–150 with 
depression of a PDMS layer used to pressurize fluid in an on-chip reservoir for 
downstream delivery. An advantage of this latter approach is that reagents may be 
directly integrated into the microfluidic chip, eliminating the need for challenging 
world-to-chip interfacing to support reagent delivery. While manual actuation offers a 
promising approach to microfluidic pumping, particularly for the implementation of 
assays where simplicity and power minimization are critical concerns, more complex 
applications requiring accurate flow rates with specific time-dependent flow profiles 
demand an alternate approach. 
5.2.3. Proposed Approaches 
Here we describe the fabrication of on-chip displacement pumps capable of 
precise and time-varying flow control through the integration of screws within threaded 
reservoirs machined into thermoplastic microfluidic chips. The screw pump concept 
represents the on-chip analog of a conventional syringe pump, with the machined 
reservoir acting as the syringe body and the threaded screw serving as both the syringe 
pump plunger and lead screw. The resulting microfluidic screw pumps are hybrid 
devices, using low cost thermoplastic substrates and stainless steel screws as disposable 
on-chip elements coupled with a reusable off-chip control system consisting of a 
miniature geared DC motor coupled to a microcontroller for software-defined control 
over pump speed. The fabrication process takes advantage of the excellent 
machinability of thermoplastic materials, and is fully compatible with existing 





comprising either an O-ring attached to a stainless steel rod or a spherical polymer ball, 
tight seals are realized within the smooth-bored plunger shaft, eliminating fluid leakage 
within the system and enabling high pressure actuation. Automated pump operation is 
demonstrated using a microcontroller platform, allowing flow rates to be precisely 
controlled with linear response over a dynamic range of 2 logs. The pumps are further 
combined with on-chip burst valves to realize fully-enclosed fluidic reservoirs capable 
of storing large fluid volumes, enabling true on-demand delivery of reagents without 
the need for external fluidics or other world-to-chip interfacings. To demonstrate the 
utility of the resulting pumps for flow control, multiple pumps are integrated into a 
hydrodynamic focusing droplet generator, with software-defined modulation of the 
flow rate ratio used to precisely adjust droplet size. 
5.3. Materials and Methods 
5.3.1. Microfluidic Chip Fabrication 
An overview of the thermoplastic chip fabrication process is presented in Figure 
5.1. Thermoplastic 1020R COP resin was purchased from Zeon Chemicals (Louisville, 
KY), and pressed in a hot press (AutoFour/15; Carver, Wabash, IN) to obtain 2 mm 
thick for microchannel substrates, and 6 mm thick plaques for reservoir substrates. 
Microchannels for flow rate measurements were directly milled into a COP plaque by 
a CNC milling machine (MDX-650A; Roland, Lake Forest, CA), with 381 μm and 1 
mm diameter endmills, and microchannels for droplet generation were milled with 75 
μm and 150 μm diameter endmills. Once channels were patterned, waste reservoirs 





a depth of 31 mm into the side of a second 6 mm thick COP substrate using either a 3.5 
mm diameter drill bit for seating a Viton O-ring seal, or 2.26 mm diameter drill bit for 
seating a Viton ball seal. Tapping tools for each screw were purchased from McMaster-
Carr (Princeton, NJ). M3×0.5 screw threads were formed by drilling a pilot hole with 
2.5 mm drill bit within the first 10 mm of the reservoir, followed by manual tapping 
with an M3×0.5 tapping tool. Similarly, M4×0.7 screw threads were formed by drilling 
a pilot hole with a 3.3 mm drill bit and threaded with a M4×0.7 tapping tool. Both COP 
substrates were cleaned by sequential sonication in methanol, acetone, and deionized 
water, then dried overnight in a vacuum oven. To smooth residual machining marks in 
the microchannels, the substrate was exposed to a decalin/ethanol (35/65 w/w) solution 
for 1 min, followed by rinsing with ethanol and overnight drying. After drying, devices 
were completed by manually aligning and sealing the microchannel and reservoir layers 
via solvent bonding by exposing the reservoir layer to a solution of decalin/ethanol 
(35/65 w/w) and applying a pressure of 2.1 MPa to the two-layer assembly at 40 °C for 
5 min in a hot press. 
Before sealing each screw reservoir, a defined volume of liquid was added from 
a pipette to fill the untapped reservoir volume for a total on-chip fluid volume of 
approximately 50 µL. Sealing of each reservoir was performed using one of three 
different methods, as shown inset in Figure. 5.1. In the simplest approach, a screw is 
partially introduced into the reservoir entrance, with sealing provided by deformation 
of the tapped COP surface during threading of the screw. Stainless steel socket cap 
screws (sizes M3×0.5 and M4×0.7) were purchased from McMaster-Carr Inc. 





(Viton) O-ring assembled onto a 3 mm diameter stainless steel rod (McMaster-Carr). 
Viton O-rings with 3.6 mm outer diameter and 1.1 mm inner diameter were purchased 
from Precision Associates (Minneapolis, MN). The rod was first cut into cut to 1.2 cm 
long segments. A groove, 0.9 mm deep and wide, was formed around the full 
circumference near one end of the rod using a lathe, and an O-ring was seated into the 
groove. The chip reservoirs were treated with a solution of cyclohexane/ethanol (1/10 
v/v) for 2 min to temporarily soften the inner walls of reservoir and form a smooth 
surface to enhance O-ring sealing. The assembled sealing rod was manually inserted 
into the on-chip reservoir, and a screw was threaded into the port until it touched the 
exposed end of the rod. In the third sealing method, the O-rings were replaced with 
2.38 mm diameter Viton balls (Precision Plastic Ball Company, Franklin Park, IL) with 
Figure 5.1. Screw pump fabrication process. (a) Starting with a thermoplastic COP 
substrate, (b) a hole is drilled into the side and (c) tapped to form female screw 
threads. (d) Vias are milled into the upper surface to connect the drilled hole to a 
microchannel previously formed in a COP capping layer, followed by (e) solvent-
assisted bonding. (f) Pump sealing configurations employed either the screw alone, 





diameters of either inserted into the reservoir bores, followed by introduction of a 
stainless steel rod and screw. 
5.3.2. Pump Control 
To enable automated software-defined pump control, a small form factor 
microcontroller board (Pro Trinket, Adafruit, New York, NY) based on the Arduino 
physical computing platform was employed. The microcontroller was interfaced with 
a compact DC motor coupled with a 1000 : 1 gearbox, providing a stall torque of 9 kg 
cm and no-load speed of 32 rev/min at 6 V coil voltage (Micro Metal Gearmotor, Pololu 
Corporation, Las Vegas, NV). A shaft coupler consisting of a stainless steel rod (0.635 
cm diameter, 2.54 cm length) and shaft adapter (1/4 inch to 3 mm adapter; Servocity, 
Winfield, KS) was fixed to a hex driver for convenient connection between the output 
shaft of the gearbox and the pumping screw integrated into the microfluidic chip. 
Software control of the screw bit rotation speed was achieved by modulating the 
average voltage applied to the DC motor through an 8-bit pulse width modulation 
(PWM) signal generated by the microcontroller with a base frequency of approximately 
500 Hz. A 5 V voltage source consisting of a 6 V battery and 5 V voltage regulator was 
connected to the motor through a power MOSFET (IRF520, Vishay Intertechnology, 
Malvern, PA) for switching the applied motor voltage directly from the 






5.3.3. Pump Performance Characterization 
Linear fluid velocity resulting from pump actuation was determined by sealing 
a volume of water containing food coloring within the on-chip pump reservoir. The 
resulting fluid motion within a downstream serpentine microchannel connected to the 
reservoir was monitored using a digital camera at 60 frames per s. Average flow 
velocities were determined based on the time required for the fluid front to traverse a 
known channel length. Volumetric flow rates were then calculated based on the known 
microchannel dimensions. Flow rates were controlled by varying the duty cycle of the 
PWM signal applied to the geared DC motor with 8-bit resolution. Theoretical flow 
rates were determined based on the applied motor speed, screw diameter or reservoir 
diameter, and thread pitch. 
Analysis of leakage pressure past the reservoir seals was performed using a 
liquid chromatography pump (PU-2089; Jasco, Easton, MD) connected to each COP 
device through a stainless steel needle press-fit into the outlet reservoir.151 The COP 
device under test was filled with DI water prior to the measurement. Under constant 
infusion of water at 1 μL/min from the outlet, pressure within COP device was 
monitored with 0.1 MPa resolution. Sealing pressure of each device was determined 
when a sudden drop in measured pressure occurred, with leakage verified by optical 





5.4. Results and Discussion 
5.4.1. Device Fabrication 
Thermoplastics are attractive materials for disposable microfluidic assays due 
in part to their exceptionally low cost, which is nearly two orders of magnitude lower 
than that of PDMS by weight. Unlike PDMS, an elastomeric material that has been 
widely used to achieve on-chip pumping in a variety of ways,137–139,141,147,152,153 the 
ability to integrate similar micropumps into thermoplastic devices is limited by the high 
stiffness associated with typical engineering thermoplastics. However, in contrast to 
elastomers, a key advantage of thermoplastics lies in the excellent machinability of 
these materials, allowing conventional machining operations such as milling, drilling, 
and tapping to be harnessed for device fabrication. Here we take advantage of these 
conventional machining methods to realize miniaturized screw-actuated displacement 
pumps integrated directly into COP thermoplastic chips. The process flow, depicted 
previously in Figure 5.1, begins with drilling reagent reservoirs into the side of a 6 mm 
thick COP plate with endmill diameter dictated by the dimensions of the screw used 
for pumping. The use of a relatively thick reservoir substrate was necessary to provide 
sufficient material to support formation of the reagent reservoirs and screw ports. While 
the manual actuation of screws inserted into the upper surfaces of thermoplastic 
microfluidic devices has been previously reported by our own group151,154 and others,21 
the current approach of positioning the screws in the side of the chip substrate enables 
the formation of significantly larger reservoir volumes for on-chip reagent storage, as 
well as providing sufficient port depth to support the integration of secondary sealing 





threads for the pump screws was straightforward, although aggressive sonication was 
found to be necessary to fully remove tapping debris from the ports. 
5.4.2. Software-Defined Flow Control 
An image of a custom controller containing two independent pump motors is 
shown in Figure 5.2(a), and sequential images showing controlled fluid flow through a 
coupled microchannel are shown in Figure 5.2(b). The stand-alone system consists of 
two geared DC motors with a coupler and hex key driver attached to each output shaft, 
a microcontroller, motor drive transistors, and regulated 5 V voltage source. By 
stacking the circuit layer, motors, and batteries, the resulting controller is compact, with 
a footprint less than 6 cm square. 
Using this controller, volumetric flow rates were measured for pumps using 
both M3 and M4 screws with Viton ball seals, with results shown in Figure 5.3. Based 
on the screw thread pitch and fabricated reservoir diameter, theoretical volumetric 
Figure 5.2. (a) Microcontroller-based screw pump for two DC motors. Two micro 
DC motors were mounted at the top layer, connected to the hex key driver via 
coupler. On the bottom layer, a microcontroller and two H-bridge circuits were 
interfaced on a circuit board. (b) Screw pump-actuated flow in microchannel using 





displacements of 2.0 μL and 2.8 μL per screw revolution are expected for the M3×0.5 
and M4×0.7 screws, respectively. A maximum flow rate of 18.1 μL/min was achieved 
for the M3 screw at 100% duty cycle, while the larger thread pitch M4 screw yielded a 
maximum flow rate of 37.3 μL/min. A video montage showing microchannel flow over 
a range of applied motor duty cycles for the case of an M4 screw pump is provided as 
electronic supplemental information.  
The higher friction associated with the larger screw resulted in increased flow 
rate variations compared with the M3 screws, with RSD as high as 14% at low duty 
cycles. Ultimately, friction limited the smallest achievable duty cycle, and thus the 
lowest flow rate, for both the M3 and M4 screw pumps. For the case of the M4 screw, 
a minimum flow rate of 1.45 μL/min was realized at 5.1% duty cycle, while the lower 
friction of the M3 screw device enabled a minimum flow rate of 0.43 μL/min at 3.5% 
duty cycle. Ultimately, the dynamic range of the screw-enabled pumps depends on 
motor performance, with the motors selected in this work reflecting a particular balance 







Figure 5.3. Flow rate of the screw-driven pump using Viton ball and rod 
configuration. (Top) Flow rate measured in full duty cycle range, and (bottom) finer 
measurement at low duty cycle. Using this configuration, flow rate can be tuned 





In conventional syringe pumps which commonly employ stepper motors for 
precise actuation, unwanted pulsatile flow can often be observed at low flow rates due 
to periodic action of the motor driving the syringe plunger. Because the integrated 
syringe pumps described here employ PWM signals for motor actuation, with a PWM 
base frequency of approximately 500 Hz, pulsatile flow at this same frequency is 
expected. Because this frequency is well above the frame rate used for video capture, 
however, no pulsatile flow was observed in our experiments. Furthermore, any 
compliance within the fluidic system serves to reject high frequency disturbances in 
the flow, with higher levels of smoothing occurring at higher input frequencies. Thus 
the integrated pumps can offer enhanced flow uniformity compared with standard off-
chip syringe pumps, although at the cost of reduced flow rate precision afforded by the 
use of stepper motors. 
5.4.3. Pump Sealing 
In the previous tests, a small amount of liquid was often observed to leak past 
the screw threads and exit the chip at higher flow rates. Characterization of the leakage 
pressure revealed that back pressures above approximately 100 kPa were sufficient to 
result in significant and routine fluid leakage for both M3 and M4 screws. In 
conventional syringe pumps, an elastomer seal attached to the tip of the syringe plunger 
serves to prevent leakage during actuation. Following a similar approach for sealing in 
the integrated screw pumps, we first sought to address the leakage issue by fabricating 
stainless steel rods equipped with circumferential grooves to house miniature O-rings 
(Figure 5.4(a)). Each rod was designed to serve as a sealed plunger which can move 





ring dimensions were chosen such that a 30% compressive strain and 9% stretching 
strain is induced when the O-ring is placed in the grooved section of the rod. Using this 
design, the resulting O-ring seals were found to prevent pump leakage at a maximum 
pressure of 0.7 ± 0.2 MPa, demonstrating their utility for low-pressure pumping. 
However, manual insertion of the miniature plunger into the screw reservoir often 
resulted in the O-ring dislodging from the shaft groove, necessitating multiple insertion 
attempts and damage to the sealing surfaces. More fundamentally, higher pumping 
pressures than those provided by the O-ring seal are commonly needed for many 
microfluidic applications. To increase the pressure limits while eliminating the chance 
of seal failure during plunger insertion, the O-ring was replaced with a simple 
fluoropolymer elastomer ball with a diameter slightly larger than that of the solvent-
polished reservoir barrel. After testing several size differences ranging from 1% to 
13%, elastomer balls 5% larger than the reservoir diameter were chosen to provide 
effective sealing without introducing excessive friction in the system. An SEM image 
of an elastomer ball partially inserted into a reservoir is shown in Figure 5.4(b). When 
using this configuration to characterize leakage pressure for the elastomer ball seals, 
Figure 5.4. (a) O-ring integrated with a machined stainless steel rod and (b) 






tested devices failed due to delamination of the bonding interface between 
microchannel and reservoir substrates, rather than leakage past the seal. In these tests, 
an average sealing pressure of 4.7 ± 1.7 MPa was measured. No seal leakage was 
observed even at the maximum recorded pressure of 6.6 MPa, confirming that the 
fluoropolymer elastomer balls serve as an excellent high pressure seal for the on-chip 
screw pumps. 
The use of solvent polishing to smooth the machined reservoir walls was found 
to be critical in enhancing device sealing when employing both the elastomer O-rings 
and balls. Without solvent polishing, damage to the Viton components was often 
observed following actuation, together with Viton residue and small amounts of fluid 
on the reservoir walls indicating an incomplete seal. Neither issue was observed for 
any of the solvent polished devices explored in this work. 
5.4.4. Burst Valve Integration 
To support on-chip packaging of reagents for integrated assays, sealing of 
liquids within the microfluidic chips is necessary. Sealing is required to prevent fluid 
loss by evaporation, to avoid potential user exposure to toxic or biologically active 
materials, and to minimize the potential for external contamination of the on-chip 
reagents. The screw pump seals serve this function on the inlet side of the pump 
reservoirs, but downstream sealing is also required to isolate fluids within the on-chip 
reservoirs. To demonstrate that fluids may be fully sealed within a thermoplastic chip 
prior to pumping, integrated screw pumps with elastomer ball seals were combined 





process.154 Briefly, each valve region was defined by selective oxidation exposure to 
UV/ozone through a mask, followed by solvent swelling of the unexposed regions to 
raise the surface by several micrometers to form small gaps at the valves, followed by 
thermal bonding to temporarily close the gaps, thereby sealing the valves with a weak 
bond that may be reversed by application a burst pressure of approximately 1.5 MPa, 
well within the pressure limits of the integrated pumps. A microfluidic device 
containing 3 independent sets of screw pumps, burst valves, and reagent reservoirs was 
fabricated, as shown in Figure 5.5. In this device, the downstream channels connect to 
a single outlet channel routed to a shared waste reservoir. Before testing burst valve 
actuation, effective sealing of the storage chambers was verified by applying vacuum 
at the reservoir and monitoring motion of liquid past the valve. While hermeticity of 
the screw pump seal was not directly tested, we note that for applications where 
hermeticity is important, reagents may be stored between a pair of on-chip burst valves 
coupled to the pump inlet, obviating the need for a truly hermetic seal at the pump 
itself. For the device shown in Figure 5.5, each screw pump was operated in sequence 
Figure 5.5. Fabricated chip containing 3 screw pumps with dye/water solutions 
stored in the screw pump reservoirs, and connected to single-use burst valves for 
hermetic sealing. Sequential independent actuation of each pump and burst valve is 





at a flow rate of approximately 10 μL/min, resulting in rapid buildup of pressure and 
opening the connected valve within 1 s following initial pump actuation. Independent 
valve opening was achieved in each of the channels, with no crosstalk between the 
fluidically-coupled valves observed. This demonstration confirms that the combination 
of sealed screw pumps and burst valves represents an effective method for on-chip 
storage and on-demand delivery of liquid reagents within thermoplastic microfluidic 
systems. 
5.4.5. Two-Phase Droplet Generation 
To further evaluate performance of the integrated screw pumps, a microfluidic 
two-phase water-in-oil droplet generator was fabricated with independent pumps for 
storage and delivery of each phase. All device inlet channels were 150 μm wide, with 
a droplet pinching region initially 88 μm wide and expanding to 150 μm. The height of 
all channels was 60 μm. A solution of dye in water with 1 wt% TWEEN 20 surfactant 
was added to the central reservoir during pump assembly, while silicone oil was added 
to the outer reservoirs coupled to the sheath flow microchannels. To maximize the 
achievable range of flow rate ratios between the two phases, the aqueous phase pump 
utilized an M3 screw while the two oil phase pumps were fabricated with M4 screws. 
To obtain uniform droplets, microchannel droplet generation requires precise 
flow rate control as well as a stable infusion for both the continuous and dispersed 
phases. The size of droplet was tuned by varying duty cycle the motors to achieve 
different flow rate ratios, with droplets monitored under an optical microscope. In our 





holding the aqueous phase M3 screw duty cycle at 5.9%. As shown in Figure 5.6, stable 
droplets with excellent size uniformity were generated under these conditions, with 
droplet diameters ranging from 54.0 ± 3.8 μm to 114.6 ± 2.3 μm. 
5.5. Conclusion 
The integration of micropumps into thermoplastic microfluidic systems 
enabling on-chip reagent storage is needed to overcome limitations associated with 
world-to-chip fluidic interfacing in these systems. The screw-actuated displacement 
micropumps described in this work present new opportunities for the development of 
disposable assays using thermoplastic microfluidics. The ability to integrate on-chip 
screws as low cost functional pumping elements, while isolating higher cost reusable 
components including motors and control circuitry in a self-contained and compact 
form factor separate from the microfluidic device, makes the technology well suited to 
the development of microfluidic assays for use in small clinical settings or for portable 
Figure 5.6. Droplet generation performed on two-motor system with Viton ball 
configuration. Dispersed phase reservoir was tapped for M3 screw then fixed at 
5.9% duty cycle. Continuous phase reservoir was tapped for M4 screw, then duty 
cycle was varied from 8.2% to 17.7%. Three images are corresponding to 8.2%, 





operation. Because software-defined flow profiles may be readily established using the 
demonstrated platform, with precise control over reagent flow rates from multiple on-
chip reservoirs, the screw-enabled pumps can be used to manipulate complex fluidic 
operations limited only be the number of motors that may be positioned around the chip 
periphery. Finally, we note that actuation of the on-chip screws may also be performed 
manually, e.g. using a handheld driver rather than servo motors, for applications where 
it is desirable to minimize system cost and complexity, or where reliance on batteries 







Chapter 6:  Conclusion 
 
6.1. Summary 
In this dissertation, we explored various microfluidic size-based separation 
techniques with the objective of developing rapid, efficient, and simple clinical sample 
preparation system for rapid detection of bacterial infection. Microfluidic techniques 
demonstrated here offered a compact, portable, and easy-to-operate solutions for 
sample preparation as well as various approaches to integrate microfluidic functions to 
maximize its efficiency even at a remote setting, or resource-poor environment.  
In the aim of developing a sample preparation platform for bacterial detection 
in blood based on microfluidic techniques, a micro-porous silica monolith was 
employed as an essential component to trigger mechanical lysis of red blood cells. The 
simple principle of lysis not only offers a strong advantages over conventional passive 
microfluidic separation methods or chemical lysis approach, but also proved its 
versatility to process different gram types, size, and shape of bacteria on a same device 
at the same operation condition. However, mechanical lysis of a cell required a strong 
pressure-driven flow to push a cell into a pore, resulted in more frequent cell clogging 
for whole blood.  
In the following two chapters, different hydrodynamic separation techniques 
were explored to improve the performance of monolith system by removing cell 
population at moderate level prior to the monolith device. A new innovative concept of 





processing of sample at the moment of blood draw. A unique thermoplastic solvent 
casting method not only enabled the microfabrication at a micron scale, but also offered 
an unconventional solution for three dimensional integration of thermoplastic 
microfluidic devices. The lab-on-a-syringe device showed how microfluidic designs 
could benefit from non-planar geometry, opening a new path toward the development 
of hybrid, multifunctional solutions using a conventional clinical tools such as 
disposable syringe. Apart from the lab-on-a-syringe, the miniaturized hydrocyclone 
was presented as another pre-processing device especially focused on throughput. 
Utilizing a 3D printing technique, a powerful separator commonly built in meter scale 
for the engineering plant was successfully miniaturized into a millimeter scale. µHC 
successfully showed particle separation at two orders of magnitude higher than the 
throughput of conventional microfluidic separation methods. Simple operation 
principle of pressure-driven flow expanded its potential toward instrumentation-free, 
portable sample preparation device and ultimately toward the POC clinical sample 
preparation. 
At last, a strategy to truly realize the idea of lab-on-chip is discussed in the 
perspective of device operation and on-chip reagent storage. A miniaturized fluid 
actuator called “screw pump” and a thermoplastic device integrated with a reagent 
storage, microfluidic design, and simple fluidic interfacing are presented. The fluidic 
actuator capable of precise flow control over a wide range, various operation mode, 
and multiple actuation combined with a simple fluidic interfacing solution not only 
benefits the microfluidic devices presented in this dissertation, but also easily adaptable 





presented here was simple and low-cost but highly stable up to several megapascal 
pressure, and miniature fluid actuator was compact, and battery-powered, minimizing 
the need of sample loading step or bulky fluid actuator which binds the current LOC 
process to the laboratory.                              
6.2. Contribution to Field 
The porous silica monolith offers an alternative approach to conventional size-
exclusive techniques for blood specimen process. Unlike the conventional fibrous 
membrane or polymer-based porous element, porous silica monolith takes advantage 
of superior mechanical rigidity, enabling the mechanical lysis of cells at whole blood 
level. Facile scaling of the sol-gel chemistry greatly improves manufacturability of 
proposed device. In contrast to many size-based separation techniques which requires 
significant size differences between the target and the other component, precise fluidic 
control, or time-consuming process, simple flow-through operation through a porous 
silica monolith offers a simple solution that is applicable to various types of bacteria 
without any system modification.  
Lab-on-a-syringe device demonstrated in this dissertation a new idea of smart 
tools for healthcare. The device utilized only a thermoplastic device and a common 
clinical tool to realize high quality micro structures in a cost-effective way compared 
to PDMS device or inorganic material. Unique thermoplastic soft lithography 
demonstrated a successful integration of microfluidic system onto a three-dimensional 
substrate, and it overcame the limitation of traditional thermoplastic fabrication 





took advantage of the shape of the substrate, and realized highly complex microfluidic 
system in an unconventional way.  
Micro hydrocyclone realized via 3D printing technique reported the first 
successful hydrocyclone in a single millimeter scale. In spite of its superb throughput 
and separation efficiency, the extremely complex internal structure of hydrocyclone 
has been a major obstacle not only for advancing the theoretical understanding in 
miniaturized scale but also for optimizing its design, configuration, or operation 
parameters. The majority of study for small scale hydrocyclone is still focused on 
simulation side due to the difficulties of realizing the µHC structure, and the µHC 
presented the first experimental efforts toward the single micron scale separation within 
a millimeter scale hydrocyclone. In addition, the successful fabrication and following 
attempts to improve the separation performance through design modification provided 
good strategies toward the application of micro hydrocyclone in clinical fields. 
Miniaturized fluid actuator with programmable controller, compact size 
coupled with highly stable reagent storage and simple interfacing methods presents a 
promising solution for various lab-on-a-chip diagnostics in a resource-limited setting, 
or in a time-sensitive situation. Programmable operator composed of cost-effective 
microprocessor combined with common DC motors demonstrated robust fluid 
manipulation, while easily multiplexed or replicated. Thermoplastic cassette-type 
device showed excellent sealing stability with a simple Viton ball, and enabled fluidic 
control at the level of hundreds nanoliters per minute by using a common screw. 





generation using two motors, which offers a strong potential of our portable miniature 
pump to replace the conventional syringe pump.                
6.3. Future Work 
6.3.1. Downstream Purification of Silica Monolith Processed Sample  
The porous silica monolith was able to selectively lyse blood cells while 
isolating bacteria without losing viability. However, to enable rapid detection of 
bacteria from processed sample, the presence of cell lysate can cause significant 
disturbance during detection. According to our DLS analysis, mechanically lysed cell 
produces lysate at the scale of one hundred nanometers, which size is separated far 
enough from the size of typical bacteria found in blood stream infection. In addition, 
due to the low population of bacteria in blood compared to other components, 
concentrating the bacterial suspension is required to maximize the detection efficiency. 
A simple solution for this objective is to add a simple filter-equipped centrifugation 
tube with defined pore size. Gravitational acceleration will direct flow pass through the 
filter element, and objects larger than the membrane size will be retained in supernatant 
solution. Decreased indicator of blood cell membrane component in supernatant 
solution will ensure the improved quality of the processed sample from porous silica 
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